Perma-Fix Environmental Services (PESI) 10-Q 6 Nov 14 2014 Q3 Quarterly report Financial data

Document_And_Entity_Informatio

Document And Entity Information	9 Months Ended
	Sep. 30, 2014	Nov. 03, 2014
Document and Entity Information [Abstract]	'	'
Entity Registrant Name	'PERMA FIX ENVIRONMENTAL SERVICES INC	'
Document Type	'10-Q	'
Current Fiscal Year End Date	'--12-31	'
Entity Common Stock, Shares Outstanding	'	11,468,843
Amendment Flag	'false	'
Entity Central Index Key	'0000891532	'
Entity Current Reporting Status	'Yes	'
Entity Voluntary Filers	'No	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Well-known Seasoned Issuer	'No	'
Document Period End Date	30-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'

Consolidated_Balance_Sheets_Un

Consolidated Balance Sheets (Unaudited) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Current assets:	'	'
Cash	$1,673,000	$333,000
Restricted cash	1,332,000	35,000
Accounts receivable, net of allowance for doubtful accounts of $1,905 and $1,932, respectively	9,798,000	8,106,000
Unbilled receivables - current	5,816,000	4,917,000
Inventories	445,000	520,000
Prepaid and other assets	3,461,000	3,084,000
Current assets related to discontinued operations	26,000	3,114,000
Total current assets	22,551,000	20,109,000
Property and equipment:	'	'
Buildings and land	19,863,000	19,486,000
Equipment	35,765,000	35,279,000
Vehicles	403,000	610,000
Leasehold improvements	11,613,000	11,625,000
Office furniture and equipment	1,911,000	2,046,000
Construction-in-progress	454,000	630,000
	70,009,000	69,676,000
Less accumulated depreciation and amortization	-46,454,000	-43,616,000
Net property and equipment	23,555,000	26,060,000
Property and equipment related to discontinued operations	681,000	1,367,000
Intangibles and other long term assets:	'	'
Permits	16,705,000	16,744,000
Goodwill	'	1,330,000
Other intangible assets – net	2,565,000	2,980,000
Unbilled receivables – non-current	275,000	302,000
Finite risk sinking fund	21,326,000	21,307,000
Other assets	1,290,000	1,401,000
Total assets	88,948,000	91,600,000
Current liabilities:	'	'
Accounts payable	3,474,000	5,462,000
Accrued expenses	5,786,000	5,201,000
Disposal/transportation accrual	2,165,000	1,385,000
Unearned revenue	5,993,000	4,149,000
Current liabilities related to discontinued operations	1,594,000	3,994,000
Current portion of long-term debt	3,765,000	2,876,000
Total current liabilities	22,777,000	23,067,000
Accrued closure costs	5,437,000	5,222,000
Other long-term liabilities	787,000	739,000
Deferred tax liabilities	1,102,000	1,012,000
Long-term liabilities related to discontinued operations	1,336,000	602,000
Long-term debt, less current portion	8,571,000	11,372,000
Total long-term liabilities	17,233,000	18,947,000
Total liabilities	40,010,000	42,014,000
Preferred Stock of subsidiary, $1.00 par value; 1,467,396 shares authorized, 1,284,730 shares issued and outstanding, liquidation value $1.00 per share plus accrued and unpaid dividends of $787 and $738, respectively	1,285,000	1,285,000
Stockholders' Equity:	'	'
Common Stock, $.001 par value; 30,000,000 and 75,000,000 shares authorized, respectively; 11,456,536 and 11,406,573 shares issued, respectively; 11,448,894 and 11,398,931 shares outstanding, respectively	11,000	11,000
Additional paid-in capital	103,654,000	103,454,000
Accumulated deficit	-57,165,000	-55,078,000
Accumulated other comprehensive (loss) income	-6,000	2,000
Less Common Stock in treasury, at cost; 7,642 shares	-88,000	-88,000
Total Perma-Fix Environmental Services, Inc. stockholders' equity	46,406,000	48,301,000
Non-controlling interest on Perma-Fix Medical S.A.	1,247,000	'
Total stockholders' equity	47,653,000	48,301,000
Total liabilities and stockholders' equity	$88,948,000	$91,600,000

Consolidated_Balance_Sheets_Un1

Consolidated Balance Sheets (Unaudited) (Parentheticals) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
Accounts receivable, net of allowance for doubtful accounts (in Dollars)	$1,905	$1,932
Preferred Stock of subsidiary, par value (in Dollars per share)	$1	$1
Preferred Stock of subsidiary, shares authorized	1,467,396	1,467,396
Preferred Stock of subsidiary, shares issued	1,284,730	1,284,730
Preferred Stock of subsidiary, shares outstanding	1,284,730	1,284,730
Preferred Stock of subsidiary, liquidation value per share	1	1
Preferred Stock of subsidiary, accrued and unpaid dividends (in Dollars)	$787	$738
Preferred stock par value (in Dollars per share)	$0.00	$0.00
Preferred stock, shares authorized	2,000,000	2,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock par value (in Dollars per share)	$0.00	$0.00
Common stock, shares authorized	30,000,000	75,000,000
Common stock, shares issued	11,456,536	11,406,573
Common stock, shares outstanding	11,448,894	11,398,931
Common Stock in treasury, at cost	7,642	7,642

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
Share data in Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Net revenues	$16,905,000	$19,072,000	$40,106,000	$61,685,000
Cost of goods sold	11,324,000	15,943,000	32,874,000	53,995,000
Gross profit	5,581,000	3,129,000	7,232,000	7,690,000
Selling, general and administrative expenses	2,733,000	3,276,000	8,916,000	10,833,000
Research and development	253,000	520,000	941,000	1,420,000
Impairment loss on goodwill	'	'	380,000	1,149,000
(Gain) loss on disposal of property and equipment	-25,000	'	-41,000	2,000
Income (loss) from operations	2,620,000	-667,000	-2,964,000	-5,714,000
Interest income	7,000	8,000	20,000	27,000
Interest expense	-138,000	-252,000	-505,000	-597,000
Interest expense-financing fees	-52,000	-40,000	-133,000	-87,000
Other	-63,000	'	-48,000	-8,000
Income (loss) from continuing operations before taxes	2,374,000	-951,000	-3,630,000	-6,379,000
Income tax expense (benefit)	30,000	-383,000	90,000	-1,943,000
Income (loss) from continuing operations, net of taxes	2,344,000	-568,000	-3,720,000	-4,436,000
Loss from discontinued operations, net of taxes	-462,000	-240,000	-1,897,000	-224,000
(Loss) gain on insurance settlement of discontinued operations, net of taxes	-11,000	'	3,530,000	'
Net income (loss)	1,871,000	-808,000	-2,087,000	-4,660,000
Net loss attributable to non-controlling interest	'	'	'	-64,000
Net income (loss) attributable to Perma-Fix Environmental Services, Inc. common stockholders	$1,871,000	($808,000)	($2,087,000)	($4,596,000)
Net income (loss) per common share attributable to Perma-Fix Environmental Services, Inc. stockholders - basic:	'	'	'	'
Continuing operations (in Dollars per share)	$0.20	($0.05)	($0.32)	($0.39)
Discontinued operations (in Dollars per share)	($0.04)	($0.02)	($0.17)	($0.02)
Gain on insurance settlement of discontinued operations, net of taxes (in Dollars per share)	'	'	$0.31	'
Net income (loss) per common share (in Dollars per share)	$0.16	($0.07)	($0.18)	($0.41)
Net income (loss) per common share attributable to Perma-Fix Environmental Services, Inc. stockholders - diluted:	'	'	'	'
Continuing operations (in Dollars per share)	$0.20	($0.05)	($0.32)	($0.39)
Discontinued operations (in Dollars per share)	($0.04)	($0.02)	($0.17)	($0.02)
Gain on insurance settlement of discontinued operations, net of taxes (in Dollars per share)	'	'	$0.31	'
Net income (loss) per common share (in Dollars per share)	$0.16	($0.07)	($0.18)	($0.41)
Number of common shares used in computing net income (loss) per share:	'	'	'	'
Basic (in Shares)	11,449	11,353	11,434	11,292
Diluted (in Shares)	11,490	11,353	11,434	11,292

Consolidated_Statements_of_Com

Consolidated Statements of Comprehensive Income (Loss) (Unaudited) (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Net income (loss)	$1,871	($808)	($2,087)	($4,660)
Other comprehensive (loss) income:	'	'	'	'
Foreign currency translation (loss) gain	-2	2	-8	'
Total other comprehensive (loss) income	-2	2	-8	'
Comprehensive income (loss)	1,869	-806	-2,095	-4,660
Comprehensive income (loss) attributable to non-controlling interest	'	'	'	-64
Comprehensive income (loss) attributable to Perma-Fix Environmental Services, Inc. stockholders	$1,869	($806)	($2,095)	($4,596)

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Net loss	($2,087)	($4,660)
Less: income (loss) on discontinued operations	1,633	-224
Loss from continuing operations	-3,720	-4,436
Depreciation and amortization	3,282	3,843
Amortization of debt discount	65	14
Amortization of fair value of customer contracts	'	-1,298
Deferred tax expense (benefit)	90	-2,068
Provision (benefit) for bad debt and other reserves	11	-315
Impairment loss on goodwill	380	1,149
(Gain) loss on disposal of plant, property and equipment	-41	2
Loss on sale of SYA subsidiary (see Note 4)	48	'
Foreign exchange loss	-8	'
Issuance of common stock for services	198	151
Stock-based compensation	-2	79
Changes in operating assets and liabilities of continuing operations:	'	'
Accounts receivable	-1,960	-783
Unbilled receivables	-1,246	1,832
Prepaid expenses, inventories and other assets	717	1,552
Accounts payable, accrued expenses and unearned revenue	801	-4,396
Cash used in continuing operations	-1,385	-4,674
Cash used in discontinued operations	-1,959	-336
Cash used in operating activities	-3,344	-5,010
Cash flows from investing activities:	'	'
Purchases of property and equipment	-375	-373
Proceeds from sale of property and equipment	133	'
Proceeds from sale of SYA subsidiary (see Note 4)	1,218	'
Non-controlling distribution/redemption	'	-508
Payment to finite risk sinking fund	-19	-27
Cash provided by (used in) investing activities of continuing operations	957	-908
Proceeds from property insurance claims of discontinued operations (see Note 10)	5,727	'
Net cash provided by (used in) investing activities	6,684	-908
Cash flows from financing activities:	'	'
Net borrowing of revolving credit	'	851
Principal repayments of long term debt	-1,977	-2,182
Preceeds from issuance of common stock	4	'
Proceeds from issuance of long-term debt	'	3,000
Cash (used in) provided by financing activities of continuing operations	-1,973	1,669
Principal repayments of long term debt for discontinued operations	-27	-27
Cash (used in) provided by financing activities	-2,000	1,642
Increase (decrease) in cash	1,340	-4,276
Cash at beginning of period	333	4,368
Cash at end of period	1,673	92
Interest paid	498	540
Income taxes paid	30	110
Issuance of Common Stock for debt	'	200
Issuance of Warrants for debt	'	$59

Note_1_Basis_of_Presentation

Note 1 - Basis of Presentation	9 Months Ended
	Sep. 30, 2014
Disclosure Text Block [Abstract]	'
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	'
	1	Basis of Presentation
	The consolidated condensed financial statements included herein have been prepared by the Company (which may be referred to as we, us or our), without an audit, pursuant to the rules and regulations of the Securities and Exchange Commission (“the Commission”). Certain information and note disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations, although the Company believes the disclosures which are made are adequate to make the information presented not misleading. Further, the consolidated condensed financial statements reflect, in the opinion of management, all adjustments (which include only normal recurring adjustments) necessary to present fairly the financial position and results of operations as of and for the periods indicated. The results of operations for the nine months ended September 30, 2014 are not necessarily indicative of results to be expected for the fiscal year ending December 31, 2014.
	The Company suggests that these consolidated condensed financial statements be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2013.
	Going Concern
	The accompanying financial statements have been prepared assuming we will continue as a going concern. Our former independent registered public accounting firm included in its report covering our 2013 audited consolidated financial statements an explanatory paragraph regarding substantial doubt about our ability to continue as a going concern. The Company’s financial position and operating results raised substantial doubt about the Company’s ability to continue as a going concern, as reflected by the accumulated deficit of $57,165,000 incurred through September 30, 2014. The accompanying financial statements do not include any adjustments that might be necessary if we are unable to continue as a going concern. During the nine months ended September 30, 2014, we incurred a net loss of $2,087,000 (which included a gain on insurance settlement of approximately $3,530,000 from our Perma-Fix of South Georgia, Inc. subsidiary which suffered a fire on August 14, 2013 (See “Note 4 – Divestitures and Discontinued Operations for further details relating to this insurance settlement)). As of September 30, 2014, we have a deficit in working capital of $226,000. Revenues for the nine months ended September 30, 2014 were $40,106,000 and were below our expectations and internal forecasts primarily due to the reduced and inconsistent (seasonal) spending of government clients operating under reduced budgets, completion of contracts, and general adverse economic conditions. However, we have seen significant improvement in our business starting in the latter part of the second quarter of 2014 and into the third quarter of 2014 with a number of sizable projects awarded to us, which is reflected by our third quarter financial results. As of September 30, 2014, the Company’s backlog was approximately $10,681,000, which increased approximately $2,986,000 from the December 31, 2013 balance and increased approximately $4,604,000 from the June 30, 2014 balance.
	Our cash flow requirements during the fiscal year 2013 were financed by cash on hand, operations, our credit facility, and debt financings. For the nine month ended September 30, 2014, we are in a positive cash flow position primarily as a result of the proceeds we received from the sale of our Schreiber, Yonley and Associates, Inc. (“SYA”) subsidiary and the insurance settlement proceeds that our lender authorized us to use for general working capital purposes (see “Note 4 – Divestitures and Discontinued Operations” for the divestiture of SYA and the insurance settlement proceeds received by the Company on June 30, 2014). We are continually reviewing operating costs and are committed to further reducing operating costs to bring them in line with revenue levels when deemed necessary.
	Our ability to achieve and maintain profitability is dependent upon our ability to successfully increase revenues, continue to cut our cost (when deemed necessary), and continue to develop our business plans of expansion into both commercial and international markets (to help offset the uncertainties of government spending in the United States of America) that will generate profitable revenues. We continue to explore all sources of increasing revenue.
	Reclassification
	To conform to our current year presentation, the Company included the $65,000 of loss on debt modification recorded during the three and nine months ended September 30, 2013 as interest expense. Approximately $37,000 of loss on debt modification was recorded in the second quarter of 2014 and included as interest expense. The amount recorded for loss on debt modification for each period noted above was not material and therefore, was included in interest expenses.

Note_2_Summary_of_Significant_

Note 2 - Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Significant Accounting Policies [Text Block]	'
	2	Summary of Significant Accounting Policies
	Our accounting policies are as set forth in the notes to the December 31, 2013 consolidated financial statements referred to above.
	Recently Adopted Accounting Standards
	In April 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-08, “Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.” ASU 2014-08, among other things, raises the threshold for disposals to qualify as discontinued operations. Under ASU 2014-08, a discontinued operation is (1) a component of an entity or group of components that has been disposed of by sale, disposed of other than by sale or is classified as held for sale that represents a strategic shift that has or will have a major effect on an entity’s operations and financial results or (2) an acquired business or nonprofit activity that is classified as held for sale on the date of the acquisition. ASU 2014-08 also requires additional disclosures for discontinued operations and new disclosures for individually material disposal transactions that do not meet the definition of a discontinued operation. This ASU is effective for annual periods beginning on or after December 15, 2014 and interim periods within that year. Early adoption of ASU 2014-08 is permitted but only for disposals (or classifications as held for sale) that have not been reported in financial statements previously issued or available for issue. The Company elected to early adopt ASU 2014-08 during the second quarter of 2014. On April 3, 2014, the Company’s Board of Directors (“Board”) approved management to pursue the sale of our wholly owned subsidiary, SYA. On July 29, 2014, the Company completed the divestiture of SYA. As a result of the adoption of ASU 2014-08, the Company has presented the divestiture of SYA within our continuing operations. The sale of SYA does not represent a strategic shift that has or will have a major effect on the Company's operations and financial results as defined by ASU 2014-08. The Company has continued to present discontinued operations as previously presented in the Company's fiscal 2013 Annual Report on Form 10-K for the discontinued operations prior to the adoption of ASU 2014-08 (see “Note 4 - Divestitures and Discontinued Operations” for further detail of the divestiture of SYA).
	Recently Issued Accounting Standards
	In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 provides a single, comprehensive revenue recognition model for all contracts with customers. The revenue guidance contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The standard will be effective for the first interim period within annual reporting periods beginning after December 15, 2016 for public entities, with no early adoption permitted. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.
	In June 2014, the FASB issued ASU 2014-12, “Compensation Stock – Compensation (Topic 718).” ASU 2014-12 applies to all reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. It requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition and follows existing accounting guidance for the treatment of performance conditions. The standard will be effective for annual periods and interim periods within those annual periods beginning after December 15, 2015, with early adoption permitted. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.
	In August 2014, the FASB issued ASU No. 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” ASU 2014-15 requires management to assess an entity’s ability to continue as a going concern, and to provide related footnote disclosure in certain circumstances. The new standard will be effective for all entities in the first annual period ending after December 15, 2016. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.

Note_3_Reduction_in_Authorized

Note 3 - Reduction in Authorized Shares	9 Months Ended
	Sep. 30, 2014
Reduction Of Authorized Shares [Abstract]	'
Reduction Of Authorized Shares [Text Block]	'
	3	Reduction in Authorized Shares
	On September 18, 2014 at the Company’s 2014 Annual Meeting of Stockholders, the Company’s stockholders approved an amendment to the Company’s Restated Certificate of Incorporation to reduce the number of shares of Common Stock the Company is authorized to issue from 75,000,000 to 30,000,000. This amendment became effective on September 19, 2014.

Note_4_Divestitures_and_Discon

Note 4 - Divestitures and Discontinued Operations	9 Months Ended
	Sep. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]	'
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]	'
	4	Divestitures and Discontinued Operations
	Divestiture of SYA
	The Company early adopted ASU 2014-08 during the second quarter of 2014. On July 29, 2014, the Company completed the sale of our wholly-owned subsidiary, SYA. As a result of the early adoption of ASU 2014-08, the divestiture of SYA is reported in continuing operations for all periods presented. The purchaser of SYA paid approximately $1,300,000 for 100% of the capital stock and $60,000 for estimated excess working capital which is subject to adjustment within 90 days of the closing date, in cash, to the Company at the closing, with $50,000 of such consideration placed in escrow for a period of one year to cover any claims by the purchaser for indemnification for certain limited types of losses incurred by the purchaser following the closing.  The proceeds received were used to pay down our revolver and used for working capital. SYA was a professional engineering and environmental consulting services company and was in the Company’s Services Segment. As of September 30, 2014, expenses related to the sale of SYA totaled approximately $92,000. The Company recorded a loss on the sale of SYA of approximately $48,000 (net of taxes of $0), which included an additional estimated excess working capital of approximately $42,000. The loss on the sale of $48,000 was included in “other” expense on our Consolidated Statements of Operations. In 2013, SYA had net revenues of $2,564,736 and a net loss of $621,288.
	Discontinued Operations
	In accordance with ASU 2014-08, the Company continues to present discontinued operations as previously presented in the Company’s fiscal 2013 Annual Report on Form 10-K prior to the adoption of ASU 2014-08 as follows:
	Our discontinued operations consist of our Perma-Fix of South Georgia, Inc. (“PFSG”) facility which met the held for sale criteria under ASC 360, “Property, Plant, and Equipment” on October 6, 2010. Our discontinued operations also encompass our Perma-Fix of Fort Lauderdale, Inc. (“PFFL”), Perma-Fix of Orlando, Inc. (“PFO”), Perma-Fix of Maryland, Inc. (“PFMD”), Perma-Fix of Dayton, Inc. (“PFD”), and Perma-Fix Treatment Services, Inc. (“PFTS”) facilities, which were divested on August 12, 2011, October 14, 2011, January 8, 2008, March 14, 2008, and May 30, 2008, respectively. Our discontinued operations also include two previously shut down locations, Perma-Fix of Michigan, Inc. (“PFMI”), and Perma-Fix of Memphis, Inc. (“PFM”).
	On August 14, 2013, our PFSG facility incurred fire damage which left it non-operational. Certain equipment and portions of the building structures were damaged. The Company carries general liability, pollution, property and business interruption, and workers compensation insurance with a maximum deductible of approximately $300,000. On June 20, 2014, the Company entered into a settlement agreement and release with one of its insurance carriers, resulting in receipt of approximately $3,850,000 in insurance settlement proceeds on June 30, 2014, which was used to pay down the Company’s Revolving Credit facility. As of September 30, 2014, the Company recognized a gain of $3,530,000 (of which a $11,000 loss was recognized in the third quarter of 2014), which was comprised of a $2,977,000 gain on disposal of property and equipment and $553,000 of expenses, clean-up costs, and business interruption recoveries. During the nine months ended September 30, 2014, the Company received $8,462,000 of insurance proceeds of which $5,727,000 was for property and equipment and $2,735,000 was for expenses, clean-up costs, and business interruption recoveries. During the twelve months ended December 31, 2013, the Company received $3,664,000 of insurance proceeds of which $1,750,000 was for property and equipment and $1,914,000 was for expenses, clean-up costs, and business interruption recoveries.
	The Company is currently evaluating options regarding the future operation of the PFSG facility. The Company continues to market our PFSG facility for sale. As required by ASC 360, based on our internal financial valuations, the Company concluded that tangible asset impairments existed for PFSG as of September 30, 2014 and recorded approximately $723,000 of asset impairment charges, of which approximately $38,000 was recorded in the third quarter of 2014, with the remaining $685,000 recorded in the second quarter of 2014. The asset impairment charges are included in “loss from discontinued operations, net of taxes.” No remaining intangible assets exist at PFSG at September 30, 2014.
	The following table summarizes the results of discontinued operations for the three and nine months ended September 30, 2014 and 2013. The operating results of discontinued operations are included in our Consolidated Statements of Operations as part of our “Income (loss) from discontinued operations, net of taxes.”
			Three Months Ended						Nine Months Ended
			September 30,						September 30,
	(Amounts in Thousands)		2014			2013			2014			2013
	Net revenues		$	—		$	311		$	—		$	1,784
	Interest expense		$	(1	)	$	(7	)	$	(7	)	$	(20	)
	Operating loss from discontinued operations		$	(462	)	$	(369	)	$	(1,897	)	$	(342	)
	Income tax benefit		$	—		$	(129	)	$	—		$	(118	)
	(Loss) gain on insurance settlement of discontinued operations		$	(11	)	$	—		$	3,530		$	—
	(Loss) income from discontinued operations		$	(473	)	$	(240	)	$	1,633		$	(224	)

Note_5_Other_Intangible_Assets

Note 5 - Other Intangible Assets and Goodwill	9 Months Ended
	Sep. 30, 2014
Disclosure Text Block [Abstract]	'
Intangible Assets Disclosure [Text Block]	'
	5	Other Intangible Assets and Goodwill
	The following table summarizes information relating to the Company’s other intangible assets:
					30-Sep-14								31-Dec-13
			Useful		Gross						Net		Gross					Net
			Lives		Carrying			Accumulated			Carrying		Carrying		Accumulated			Carrying
			(Years)		Amount			Amortization			Amount		Amount		Amortization			Amount
	Intangibles (amount in thousands)
	Patent		18-Aug		$	528		$	(158	)	$	370	$	514	$	(155	)	$	359
	Software		3			372			(305	)		67		379		(258	)		121
	Non-compete agreement		1.2			265			(265	)		—		265		(174	)		91
	Customer contracts		.5			790			(790	)		—		790		(790	)		—
	Customer relationships		12			3,370			(1,242	)		2,128		3,370		(961	)		2,409
	Total				$	5,325		$	(2,760	)	$	2,565	$	5,318	$	(2,338	)	$	2,980
	The intangible assets are amortized on a straight-line basis over their useful lives with the exception of customer relationships which are being amortized using an accelerated method.
	The following table summarizes the expected amortization over the next five years for our definite-lived intangible assets (which include the one definite-lived permit at our Diversified Scientific Services, Inc. (“DSSI”) subsidiary):
							Amount
				Year			(In thousands)
				2014 (remaining)			$	117
				2015				459
				2016				419
				2017				385
				2018				355
							$	1,735
	Amortization expense relating to intangible assets and our one definite-lived permit for the Company was $149,000 and $501,000 for the three and nine months ended September 30, 2014, respectively, and $185,000 and $528,000 for the three and nine months ended September 30, 2013, respectively.
	Goodwill Impairment
	On April 3, 2014, the Company’s Board approved management to pursue the sale of our SYA subsidiary. As permitted by ASC Topic 350 “Intangibles – Goodwill and Other,” when an impairment indicator arises, the Company may recognize its best estimate of that impairment loss. Based on the Company’s preliminary analysis prepared as of June 30, 2014, the Company recorded a goodwill impairment charge of $380,000 during the three months ended June 30, 2014 for the SYA reporting unit. On July 29, 2014, the Company completed the divestiture of SYA (see Note 4 – “Divestitures and Discontinued Operations – Divestiture of SYA”). The Company determined that there was no change in the estimated goodwill impairment recorded above upon the divestiture of SYA on July 29, 2014.
	During the second quarter of 2013, the Company recorded a goodwill impairment charge of $1,149,000 which represented the total goodwill for our CH Plateau Remediation Company (“CHPRC”) reporting unit, our operation under the CHPRC subcontract. This subcontract expired on September 30, 2013.
	The impairment charges noted above are noncash in nature and did not affect our liquidity or cash flows from operating activities. Additionally, the goodwill impairment had no effect on our borrowing availability or covenants under our credit facility agreement.

Note_6_Stock_Plans_and_Stock_B

Note 6 - Stock Plans and Stock Based Compensation	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	'
	6	Stock Plans and Stock Based Compensation
	The Company has certain stock option plans under which it awards incentive and non-qualified stock options to employees, officers, and outside directors. Stock options granted to employees have either a ten year contractual term with one-fifth yearly vesting over a five year period or a six year contractual term with one-third yearly vesting over a three year period. Stock options granted to outside directors have a ten year contractual term with a vesting period of six months.
	On July 10, 2014, the Company granted an aggregate of 55,000 incentive stock options (“ISOs”) from the Company’s 2010 Stock Option Plan to certain employees, of which 45,000 ISOs were granted to the Company’s Chief Operating Officer (“COO” who was appointed March 20, 2014). The ISOs granted were for a contractual term of six years with one-third yearly vesting over a three year period. The exercise price of the ISOs was $5.00 per share, which was equal to our closing stock price as reported on Nasdaq on the date of grant.
	On September 18, 2014, the Company granted an aggregate of 16,800 non-qualified stock options (“NQSOs”) from the Company’s 2003 Outside Directors Stock Plan to our seven re-elected directors at our Annual Meeting of Stockholders held on September 18, 2014. The NQSOs granted were for a contractual term of ten years with a vesting period of six months. The exercise price of the NQSOs was $3.70 per share, which was equal to our closing stock price the day preceding the grant date, pursuant to the 2003 Outside Directors Stock Plan.
	As of September 30, 2014, the Company had an aggregate of 76,000 employee stock options outstanding (from the 2004 and 2010 Stock Option Plans), of which 21,000 are vested. The weighted average exercise price of the 21,000 outstanding and fully vested employee stock options is $7.13 with a remaining weighted contractual life of 0.3 years. Additionally, the Company had an aggregate of 170,343 outstanding director stock options (from the 2003 Outside Directors Stock Plans), of which 153,543 are vested. The weighted average exercise price of the 153,543 outstanding and fully vested director stock options is $9.30 with a remaining weighted contractual life of 4.9 years.
	The summary of the Company’s total Stock Plans as of September 30, 2014, as compared to September 30, 2013, and changes during the periods then ended, are presented below. The Company’s Plans consist of the 2004 and 2010 Stock Option Plans and the 2003 Outside Directors Stock Plans:
			Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term			Aggregate Intrinsic Value
	Options outstanding Janury 1, 2014			362,800		$	9.53
	Granted			71,800			4.7
	Exercised			(1,257	)		2.79				$	2,319
	Forfeited			(187,000	)		10.04
	Options outstanding End of Period (1)			246,343			7.77		5.1		$	23,065
	Options Exercisable at September 30, 2014(1)			174,543		$	9.04		4.4		$	21,049
	Options Vested and expected to be vested at September 30, 2014			237,543		$	7.87		5		$	23,065
			Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term			Aggregate Intrinsic Value
	Options outstanding Janury 1, 2013			528,800		$	9.82
	Granted			18,000			2.79
	Exercised		─			─					$	─
	Forfeited			(156,000	)		8.28
	Options outstanding End of Period (2)			390,800			9.66		3.2		$	15,900
	Options Exercisable at September 30, 2013(2)			352,800		$	10.11		2.9		$	─
	Options Vested and expected to be vested at September 30, 2013			390,800		$	9.66		3.2		$	15,900
	(1) Options with exercise prices ranging from $2.79 to $14.75
	(2) Options with exercise prices ranging from $5.50 to $14.75
	The Company follows FASB ASC 718, “Compensation – Stock Compensation” (“ASC 718”) to account for stock-based compensation. ASC 718 requires all stock-based payments to employees, including grants of employee stock options, to be recognized in the income statement based on their fair values.
	The Company estimates fair value of stock options using the Black-Scholes valuation model. Assumptions used to estimate the fair value of stock options granted include the exercise price of the award, the expected term, the expected volatility of the Company’s stock over the option’s expected term, the risk-free interest rate over the option’s expected term, and the expected annual dividend yield. The fair value of the options granted during the nine months ended September 30, 2014 and 2013 and the related assumptions used in the Black-Scholes option model used to value the options granted were as follows (No options were granted to employees during the nine months ended September 30, 2013):
			Outside Director Stock Options Granted
			30-Sep-14			30-Sep-13
	Weighted-average fair value per share		$	2.73		$	1.96
	Risk -free interest rate (1)			2.63%			2.92%
	Expected volatility of stock (2)			59.59%			58.88%
	Dividend yield			None			None
	Expected option life (3) (years)			10			10
			Employee Stock Option Granted
			as of September 30, 2014
	Weighted-average fair value per share		$	2.88
	Risk -free interest rate (1)			1.91%
	Expected volatility of stock (2)			61.84%
	Dividend yield			None
	Expected option life (3) (years)			6
	(1) The risk-free interest rate is based on the U.S. Treasury yield in effect at the grant date over the expected term of the option.
	(2) The expected volatility is based on historical volatility from our traded Common Stock over the expected term of the option.
	(3) The expected option life is based on historical exercises and post-vesting data.
	The following table summarizes stock-based compensation recognized, which is included in selling, general and administrative expenses, for the three and nine months ended September 30, 2014 and 2013 for our employee and director stock options.
			Three Months Ended					Nine Months Ended
	Stock Options		September 30,					September 30,
			2014			2013		2014			2013
	Employee Stock Options		$	12,000		$	22,000	$	(27,000	)	$	58,000
	Director Stock Options			3,000			4,000		25,000			21,000
	Total		$	15,000		$	26,000	$	(2,000	)	$	79,000
	The Company recognized stock-based compensation expense using a straight-line amortization method over the requisite service period, which is the vesting period of the stock option grant. ASC 718 requires that stock based compensation expense be based on options that are ultimately expected to vest. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. The Company has generally estimated forfeiture rates based on historical trends of actual forfeitures. When actual forfeitures vary from our estimates, the Company recognizes the difference in compensation expense in the period the actual forfeitures occur or when options vest. The total stock-based compensation expense for the nine months ended September 30, 2014 included a reduction in expense of approximately $54,000 resulting from the forfeiture of options by Mr. Jim Blankenhorn, our previous COO, who voluntarily resigned from the Company effective March 28, 2014. The COO was granted an option from the Company’s 2010 Stock Option Plan on July 25, 2011, which provided for the purchase of up to 60,000 shares of the Company’s Common Stock at $7.85 per share. The options had a six year contractual term with one-third yearly vesting over a three year period. As of September 30, 2014, the Company has approximately $181,000 of total unrecognized compensation cost related to unvested options, of which $36,000 is expected to be recognized in remaining 2014, $73,000 in 2015, $53,000 in 2016, with the remaining $19,000 in 2017.

Note_7_CEE_Opportunity_Partner

Note 7 - CEE Opportunity Partners Poland S.A (n/k/a Perma-Fix Medical S.A.)	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Business Combination Disclosure [Text Block]	'
	7	CEE Opportunity Partners Poland S.A (n/k/a Perma-Fix Medical S.A.)
	On April 4, 2014, the Company completed the acquisition of 80% of a Polish Company, CEE Opportunity Partners Poland S.A. (“the Polish shell”), a publicly traded shell company on the NewConnect (alternative share market run by the Warsaw Stock Exchange) in Poland, for $1.00 (U.S.) and sold to the Polish shell all of the shares of Perma-Fix Medical Corporation, a Delaware corporation (“PF Medical”) organized by the Company. PF Medical’s only asset was a worldwide license granted by the Company to use, develop and market the new process and technology developed by the Company in the production of Technetium-99 (Tc-99m) for medical diagnostic applications. Since the acquired shell company does not meet the definition of a business under Accounting Standards Codification (“ASC”) 805, “Business Combinations”, the transaction was accounted for as a capital transaction. The Company renamed the Polish shell to Perma-Fix Medical S.A (“PF Medical S.A.”). The primary purpose of PF Medical S.A. is to provide a financing vehicle for the development and marketing of its medical isotope (Tc-99m) technology used in medical diagnostic testing for potential use throughout the world.
	During August, 2014, PF Medical S.A. executed stock subscription agreements totaling approximately $2,550,000 for its Series E Common Stock to non-U.S. persons in an offshore private placement under Regulation S promulgated under the Securities Act of 1933, as amended (“Securities Act”). The closing of this transaction is subject to approvals by the Polish court and compliance with certain other legal requirements under Polish law. In connection with this transaction, as of September 30, 2014, PF Medical S.A. has received approximately $1,247,000 for 125,159 shares (before deduction for commissions and legal expenses relating to this offering), which is being held in an escrow account until the appropriate approvals are obtained and certain legal compliance requirements under Polish securities law are completed. The Company expects that the approvals and necessary requirements will be obtained and completed during November 2014. The Company has recorded the amount held in escrow as restricted cash on the Consolidated Balance Sheet. PF Medical S.A. expects to receive another approximately $553,000 for 56,680 shares related to this transaction by January 2015. PF Medical S.A. further expects to receive the remaining approximately $750,000, prior to any commission, on or prior to August 17, 2015, for payment of the remaining 68,161 of such shares. The unpaid shares as of September 30, 2014 in this transaction were accounted for as subscription receivables and are offset against non-controlling interest. If PF Medical S.A. is not paid for the 68,161 shares on or prior to August 17, 2015, PF Medical S.A. has the option to have the purchaser of such shares transfer all of its rights, title and interest in such shares to PF Medical S.A. or for PF Medical S.A. be paid for the 68,161 shares with shares in another publicly traded company. Assuming PF Medical S.A. is paid for all of the shares sold in the offshore private placement, the Company will own approximately 64% of the outstanding shares of PF Medical S.A. If PF Medical S.A. is not paid for the 68,161 shares as provided above and such shares are transferred back to PF Medical S.A., then, in such event, the Company will own approximately 68% of the outstanding shares of PF Medical S.A. This is neither an offer to sell nor a solicitation of an offer to buy PF Medical S.A.’s E Common Stock or any other securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful. PF Medical S.A.’s E Common Stock is not registered under the Securities Act or any state securities laws and may not be offered or sold in the U.S. absent registration or applicable exemption from registration from the registration requirements under the Securities Act and applicable state securities laws. As a result, the share certificate or purchase confirmation issued in connection with such private placement of PF Medical S.A.’s E Common Stock will be required to bear a legend describing the restrictions of transferring such to U.S. persons and prohibiting hedging transactions in such shares unless in compliance with the Securities Act.

Note_8_Income_Loss_Per_Share

Note 8 - Income (Loss) Per Share	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Earnings Per Share [Text Block]	'
	8	Income (Loss) Per Share
	Basic income (loss) per share excludes any dilutive effects of stock options, warrants, and convertible preferred stock. In periods where they are anti-dilutive, such amounts are excluded from the calculations of dilutive earnings per share. Net loss attributable to non-controlling interests are excluded from loss from continuing operations in the below calculation in accordance with ASC 260, “Earnings Per Share.”
	The following is a reconciliation of basic income (loss) per share to diluted net income (loss) per share for the three and nine months ended September 30, 2014 and 2013:
			Three Months Ended						Nine Months Ended
			September 30,						September 30,
			(Unaudited)						(Unaudited)
	(Amounts in Thousands, Except for Per Share Amounts)		2014			2013			2014			2013
	Income (loss) per share from continuing operations attributable to Perma-Fix Environmental Services, Inc. common stockholders
	Income (loss) from continuing operations		$	2,344		$	(568	)	$	(3,720	)	$	(4,372	)
	Basic income (loss) per share		$	0.2		$	(.05	)	$	(.32	)	$	(.39	)
	Diluted income (loss) per share		$	0.2		$	(.05	)	$	(.32	)	$	(.39	)
	Loss per share from discontinued operations attributable to Perma-Fix Environmental Services, Inc. common stockholders
	Loss from discontinued operations		$	(462	)	$	(240	)	$	(1,897	)	$	(224	)
	Basic loss per share		$	(.04	)	$	(.02	)	$	(.17	)	$	(.02	)
	Diluted loss per share		$	(.04	)	$	(.02	)	$	(.17	)	$	(.02	)
	(Loss) income per share from insurance settlement of discontinued operations, net of taxes attributable to Perma-Fix Environmental Services, Inc. common stockholders
	(Loss) gain on insurance settlement of discontinued operations, net of taxes		$	(11	)	$	―		$	3,530		$	―
	Basic income per share		$	―		$	―		$	0.31		$	―
	Diluted income per share		$	―		$	―		$	0.31		$	―
	Weighted average common shares outstanding – basic			11,449			11,353			11,434			11,292
	Potential shares exercisable under stock option plans			8		―			―			―
	Potential shares upon exercise of Warrants			33		―			―			―
	Weighted average shares outstanding – diluted			11,490			11,353			11,434			11,292
	Potential shares excluded from above weighted average share calculations due to their anti-dilutive effect include:
	Upon exercise of stock options			207			391			207			373
	Upon exercise of Warrants		―			―			―			―

Note_9_Long_Term_Debt

Note 9 - Long Term Debt	9 Months Ended
	Sep. 30, 2014
Disclosure Text Block [Abstract]	'
Long-term Debt [Text Block]	'
	9	Long Term Debt
	Long-term debt consists of the following at September 30, 2014 and December 31, 2013:
	(Amounts in Thousands)		September 30,		December 31,
			2014		2013
	Revolving Credit facility dated October 31, 2011, borrowings based upon eligible accounts receivable, subject to monthly borrowing base calculation, variable interest paid monthly at our option of prime rate (3.25% at September 30, 2014) plus 2.0% or London Interbank Offer Rate ("LIBOR") plus 3.0%, balance due October 31, 2016. Effective interest rate for the first nine months of 2014 was 4.2%. (1)		$	—	$	—
	Term Loan dated October 31, 2011, payable in equal monthly installments of principal of $190, balance due in October 31, 2016, variable interest paid monthly at option of prime rate plus 2.5% or LIBOR plus 3.5%. Effective interest rate for the first nine months of 2014 was 3.8%. (1)			9,523		11,238
	Promissory Note dated February 12, 2013, payable in monthly installments of $10, which includes interest and principal, starting February 28, 2013, interest accrues at annual rate of 6.0%, balance due January 31, 2015. (2)			40		127
	Promissory Note dated August 2, 2013, payable in twelve monthly installments of interest only, starting September 1, 2013 and twenty-four monthly installments of $125 in principal plus accrued interest. Interest accrues at annual rate of 2.99%. (2) (3)			2,717		2,777
	Various capital lease and promissory note obligations, payable 2014 to 2016, interest at rates ranging from 5.2% to 6.0%.			64		141
				12,344		14,283
	Less current portion of long-term debt			3,765		2,876
	Less long-term debt related to assets held for sale			8		35
			$	8,571	$	11,372
	(1) Our Revolving Credit facility is collateralized by our accounts receivable and our Term Loan is collateralized by our property, plant, and equipment.
	(2) Uncollateralized note.
	(3) Net of debt discount of ($158,000) and ($223,000) for September 30, 2014 and December 31, 2013, respectively. See “Promissory Notes” below for additional information.
	Revolving Credit and Term Loan Agreement
	The Company entered into an Amended and Restated Revolving Credit, Term Loan and Security Agreement, dated October 31, 2011, (“Agreement”), with PNC Bank, National Association (“PNC”), acting as agent and lender. The Agreement, as amended (“Amended Loan Agreement”), provides us with the following credit facilities: (a) up to $12,000,000 revolving credit facility (reduced from $18,000,000 pursuant to an amendment dated April 14, 2014) (“Revolving Credit”), subject to the amount of borrowings based on a percentage of eligible receivables (as defined) and (b) a term loan (“Term Loan”) of $16,000,000, which requires monthly installments of approximately $190,000 (based on a seven-year amortization). As a result of the reduction in the maximum borrowing Revolving Credit noted above, the Company recorded approximately $37,000 in loss on debt modification (included in interest expense) during the second quarter of 2014 in accordance with ASC 470-50, “Debt – Modification and Extinguishment.”
	On July 25, 2014, the Company entered into Amendment 5 to the Amended Loan Agreement. This Amendment added our Perma-Fix of Canada, Inc. subsidiary as a guarantor under our credit facility. On July 28, 2014, the Company entered into Amendment 6 to the Amended Loan Agreement. This Amendment authorized the Company to sell our SYA subsidiary and released a hold by PNC which allows the Company to use the $3,850,000 insurance settlement proceeds received on June 30, 2014 by our PFSG subsidiary for working capital purposes but placed an indefinite reduction on our borrowing availability by $1,500,000. As a condition of Amendment 6, the Company agreed to pay PNC a fee of $15,000, which is being amortized over the term of the Amended Loan Agreement. All other terms of the Amended Loan Agreement remains principally unchanged.
	The Amended Loan Agreement terminates as of October 31, 2016, unless sooner terminated. The Company may terminate the Amended Loan Agreement upon 90 days’ prior written notice and upon payment in full of our obligations under the Amended Loan Agreement. No early termination fee shall apply if we pay off our obligations under the Amended Loan Agreement after October 31, 2013.
	As of September 30, 2014, the excess availability under our revolving credit was $8,558,000, based on our eligible receivables and includes the indefinite reduction of borrowing availability of $1,500,000 as discussed above.
	Our credit facility with PNC contains certain financial covenants, along with customary representations and warranties. A breach of any of these financial covenants, unless waived by PNC, could result in a default under our credit facility allowing our lender to immediately require the repayment of all outstanding debt under our credit facility and terminate all commitments to extend further credit. The fixed charge coverage ratio requirement for the first quarter of 2014 was waived by PNC. The Company met its fixed charge coverage ratio in the second and third quarters of 2014 and expects to meet its quarterly fixed charge coverage ratio requirement in the remaining quarter of 2014; however, if the Company fails to meet the minimum quarterly fixed charge coverage ratio requirement in the remaining quarter of 2014 and PNC does not waive the non-compliance or further revise our covenant so that the Company is in compliance, our lender could accelerate the repayment of borrowings under our credit facility. In the event that our lender accelerates the payment of our borrowings, the Company may not have sufficient liquidity to repay our debt under our credit facility and other indebtedness.
	Promissory Notes
	On February 12, 2013, the Company entered into an unsecured promissory note (“the new note”) with Timios National Corporation (“TNC” and formerly known as Homeland Security Capital Corporation) in the principal amount of approximately $230,000 as a result of a settlement with TNC in connection with certain claims that the Company asserted against TNC for breach of certain representations and covenant subsequent to our acquisition of Safety & Ecology Holdings Corporation and its subsidiaries (collectively known as Safety and Ecology Corporation or “SEC”) from TNC on October 31, 2011 (See payment terms of this promissory note in the table above). The new note was entered into as a result of the settlement in which a previously issued promissory note (with principal balance of $1,460,000 at February 12, 2013) that the Company entered into with TNC as partial consideration of the purchase price of SEC was cancelled and terminated and replaced with the new note. The outstanding principal balance of the new note as of September 30, 2014, was approximately $40,000. The new note provides the Company the right to prepay such at any time without interest or penalty.
	In the event of default of the new note payable to TNC by the Company, TNC has the option to convert the unpaid portion of the new note into a number of whole shares of the Company’s restricted Common Stock. The number of shares of the Company’s restricted Common Stock issuable is determined by the principal amount owing under the new note at the time of default plus all accrued and unpaid interest and expenses (as defined) divided by the average of the closing price per share of the Company’s Common Stock as reported by the primary national securities exchange on which the Company’s Common Stock is traded during the 30 consecutive trading day period ending on the trading day immediately prior to receipt by the Company of TNC’s written notice of its election to receive the Company’s restricted Common Stock as a result of the event of default by the Company, with the number of shares of the Company’s Common Stock issuable upon such default subject to certain limitations.
	On August 2, 2013, the Company completed a lending transaction with Messrs. Robert Ferguson and William Lampson (“collectively, the “Lenders”), whereby the Company borrowed from the Lenders the sum of $3,000,000 pursuant to the terms of a Loan and Security Purchase Agreement and promissory note (the “Loan”) (See payment terms of this promissory note in the table above). The Lenders are stockholders of the Company, having received shares of our Common Stock in connection with the acquisition of our Perma-Fix Northwest Richland, Inc. subsidiary (“PFNWR”) in June 2007. The proceeds from the Loan were used for general working capital purposes. In connection with this Loan, the Lenders entered into a Subordination Agreement dated August 2, 2013, with the Company’s credit facility lender, whereby the Lenders agreed to subordinate payment under the Loan, and agreed that the Loan will be junior in right of payment to the credit facility in the event of default or bankruptcy or other insolvency proceeding by the Company. As consideration for the Company receiving the Loan, the Company issued a Warrant to each Lender to purchase up to 35,000 shares of the Company’s Common Stock at an exercise price based on the closing price of the Company’s Common Stock at the closing of the transaction which was determined to be $2.23. The Warrants are exercisable six months from August 2, 2013 and expire on August 2, 2016. The fair value of the Warrants was estimated to be approximately $59,000 using the Black-Scholes option pricing model. As further consideration for the Loan, the Company also issued an aggregate 90,000 shares of the Company’s Common Stock, with each Lender receiving 45,000 shares. The Company determined the fair value of the 90,000 shares of Common Stock to be approximately $200,000 which was based on the closing price of the stock of $2.23 per share on August 2, 2013. The fair value of the Warrants and Common Stock and the related closing fees incurred from the transaction were recorded as a debt discount, which is being amortized using the effective interest method over the term of the loan as interest expense – financing fees.
	In the event of default of the promissory note by the Company, the Lenders have the option to receive a cash payment equal to the amount of the unpaid principal balance plus all accrued and unpaid interest (“Payoff Amount”), or the number of whole shares of the Company’s Common Stock equal to the Payoff Amount divided by the closing bid price of the Company’s Common Stock on the date immediately prior to the date of default of the promissory note, as reported by the primary national securities exchange on which the Company’s Common Stock is traded. The maximum number of payoff shares is restricted to less than 20% of the outstanding equity.

Note_10_Commitments_and_Contin

Note 10 - Commitments and Contingencies	9 Months Ended
	Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies Disclosure [Text Block]	'
	10	Commitments and Contingencies
	Hazardous Waste
	In connection with our waste management services, the Company handles hazardous waste, non-hazardous waste, low level radioactive waste and mixed waste (containing both hazardous and low level radioactive waste), which the Company transports to our own, or other, facilities for destruction or disposal. As a result of disposing of these substances, in the event any cleanup is required, the Company could be a potentially responsible party for the costs of the cleanup notwithstanding any absence of fault on our part.
	Legal Matters
	In the normal course of conducting our business, the Company is involved in various litigation. We are not a party to any litigation or governmental proceeding which our management believes could result in any judgments or fines against us that would have a material adverse effect on our financial position, liquidity or results of future operations.
	Insurance
	The Company has a 25-year finite risk insurance policy entered into in June 2003 with American International Group, Inc. (“AIG”), which provides financial assurance to the applicable states for our permitted facilities in the event of unforeseen closure. The policy, as amended, provides for a maximum allowable coverage of $39,000,000 and has available capacity to allow for annual inflation and other performance and surety bond requirements. All of the required payments for this finite risk insurance policy, as amended, were made by the first quarter of 2012. As of September 30, 2014, our financial assurance coverage amount under this policy totaled approximately $38,679,000. The Company has recorded $15,424,000 in our sinking fund related to the policy noted above in other long term assets on the accompanying balance sheets, which includes interest earned of $953,000 on the sinking fund as of September 30, 2014. Interest income for three and nine months ended September 30, 2014, was approximately $5,000 and $15,000, respectively. On the fourth and subsequent anniversaries of the contract inception, the Company may elect to terminate this contract. If the Company so elects, AIG is obligated to pay us an amount equal to 100% of the sinking fund account balance in return for complete releases of liability from both us and any applicable regulatory agency using this policy as an instrument to comply with financial assurance requirements.
	In August 2007, the Company entered into a second finite risk insurance policy for our PFNWR facility with AIG. The policy provided an initial $7,800,000 of financial assurance coverage with an annual growth rate of 1.5%, which at the end of the four year term policy, provides maximum coverage of $8,200,000. The Company has made all of the required payments on this policy. As of September 30, 2014, the Company has recorded $5,902,000 in our sinking fund related to this policy in other long term assets on the accompanying balance sheets, which includes interest earned of $202,000 on the sinking fund as of September 30, 2014. Interest income for the three and nine months ended September 30, 2014 was approximately $1,000 and $4,000, respectively. This policy is renewed annually at the end of the four year term with a nominal fee for the variance between the coverage requirement and the sinking fund balance. The Company has renewed this policy annually from 2011 to 2014 (with fees ranging from $41,000 to $46,000 annually). All other terms of the policy remain substantially unchanged.

Note_11_Operating_Segments

Note 11 - Operating Segments	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Segment Reporting Disclosure [Text Block]	'
	11	Operating Segments
	In accordance with ASC 280, “Segment Reporting”, the Company defines an operating segment as a business activity:
	●	from which we may earn revenue and incur expenses;
	●	whose operating results are regularly reviewed by the Chief Operating Officer to make decisions about resources to be allocated to the segment and assess its performance; and
	●	for which discrete financial information is available.
	The Company currently has two reporting segments, which are based on a service offering approach. This however, excludes corporate headquarters, which does not generate revenue, our discontinued operations, which includes all facilities as discussed in “Note 4 – Divestiture and Discontinued Operations and Divestitures”, and PF Medical S.A., a developmental entity whose primary purpose at this time is the research and development and marketing of medical isotope technology used in medical diagnostic testing (which is not generating any revenues).
	Our reporting segments are defined as follows:
	TREATMENT SEGMENT, which includes:
		-	nuclear, low-level radioactive, mixed waste (containing both hazardous and low-level radioactive constituents), hazardous and non-hazardous waste treatment, processing and disposal services primarily through four uniquely licensed and permitted treatment and storage facilities; and
		-	research and development activities to identify, develop and implement innovative waste processing techniques for problematic waste streams.
	SERVICES SEGMENT, which includes:
		-	On-site waste management services to commercial and government customers;
		-	Technical services, which include:
		o	professional radiological measurement and site survey of large government and commercial installations using advance methods, technology and engineering;
		o	integrated Occupational Safety and Health services including industrial hygiene (“IH”) assessments; hazardous materials surveys, e.g., exposure monitoring; lead and asbestos management/abatement oversight; indoor air quality evaluations; health risk and exposure assessments; health & safety plan/program development, compliance auditing and training services; and Occupational Safety and Health Administration (“OSHA”) citation assistance;
		o	global technical services providing consulting, engineering, project management, waste management, environmental, and decontamination and decommissioning field, technical, and management personnel and services to commercial and government customers; and
		o	augmented engineering services (through our Schreiber, Yonley & Associates, Inc. subsidiary (“SYA”) – which was divested July 29, 2014) providing consulting environmental services to industrial and government customers:
		■	including air, water, and hazardous waste permitting, air, soil and water sampling, compliance reporting, emission reduction strategies, compliance auditing, and various compliance and training activities; and
		■	engineering and compliance support to other segments;
		-	Nuclear services, which include:
		o	technology-based services including engineering, decontamination and decommissioning (“D&D”), specialty services and construction, logistics, transportation, processing and disposal;
		o	remediation of nuclear licensed and federal facilities and the remediation cleanup of nuclear legacy sites. Such services capability includes: project investigation; radiological engineering; partial and total plant D&D; facility decontamination, dismantling, demolition, and planning; site restoration; site construction; logistics; transportation; and emergency response; and
		-	A company owned equipment calibration and maintenance laboratory that services, maintains, calibrates, and sources (i.e., rental) of health physics, IH and customized nuclear, environmental, and occupational safety and health (“NEOSH”) instrumentation.
	The table below presents certain financial information of our operating segments as of and for the three and nine months ended September 30, 2014 and 2013 (in thousands).
	Segment Reporting for the Quarter Ended September 30, 2014
			Treatment			Services			Segments			Corporate (1)			PF Medical			Consolidated
									Total						S.A. (1)			Total
	Revenue from external customers		$	12,705		$	4,200		$	16,905		$	—			—		$	16,905
	Intercompany revenues			—			19			19			—			—			—
	Gross profit			4,943			638			5,581			—			—			5,581
	Interest income		—				—			—			7			—			7
	Interest expense			(10	)		—			(10	)		(128	)		—			(138	)
	Interest expense-financing fees			—			—			—			(52	)		—			(52	)
	Depreciation and amortization			748			213			961			12			—			973
	Segment profit (loss)			3,985			10			3,995			(1,422	)		(229	)		2,344
	Expenditures for segment assets			3			39			42			—			—			42
	Segment Reporting for the Quarter Ended September 30, 2013
			Treatment			Services			Segments			Corporate (1)			PF Medical			Consolidated
									Total						S.A. (1)			Total
	Revenue from external customers		$	8,929		$	10,143		$	19,072		$	—			—		$	19,072
	Intercompany revenues			82			11			93			—			—			—
	Gross profit			1,801			1,328			3,129			—			—			3,129
	Interest income			—			—			—			8			—			8
	Interest expense			(10	)		(1	)		(11	)		(241	)		—			(252	)
	Interest expense-financing fees			—			—			—			(40	)		—			(40	)
	Depreciation and amortization			999			248			1,247			20			—			1,267
	Segment profit (loss)			616			387			1,003			(1,571	)		—			(568	)
	Expenditures for segment assets			192			6			198			—			—			198
	Segment Reporting for the Nine Months Ended September 30, 2014
			Treatment			Services			Segments			Corporate (1)			PF Medical			Consolidated
									Total						S.A. (1)			Total
	Revenue from external customers		$	29,773		$	10,333		$	40,106		$	—			—		$	40,106
	Intercompany revenues			—			64			64			—			—			—
	Gross profit			6,379			853			7,232			—			—			7,232
	Interest income			—			—			—			20			—			20
	Interest expense			(35	)		(1	)		(36	)		(469	)		—			(505	)
	Interest expense-financing fees			—			2			2			(135	)		—			(133	)
	Depreciation and amortization			2,535			709			3,244			38			—			3,282
	Segment profit (loss)			2,977			(1,981	)		996			(4,302	)		(414	)		(3,720	)
	Expenditures for segment assets			334			41			375			—			—			375
	Segment Reporting for the Nine Months Ended September 30, 2013
			Treatment			Services			Segments			Corporate (1)			PF Medical			Consolidated
									Total						S.A. (1)			Total
Revenue from external customers		$	26,379		$	35,306		$	61,685		$	—			—		$	61,685
Intercompany revenues			1,149			66			1,215			—			—			—
Gross profit			3,968			3,722			7,690			—			—			7,690
Interest income			—			—			—			27			—			27
Interest expense			(38	)		3			(35	)		(562	)		—			(597	)
Interest expense-financing fees			—			—			—			(87	)		—			(87	)
Depreciation and amortization			3,063			708			3,771			72			—			3,843
Segment profit (loss)			524			(432	)		92			(4,528	)		—			(4,436	)
Expenditures for segment assets			367			6			373			—			—			373
(1) Amounts reflect the activity for corporate headquarters and PF Medical S.A. not included in the segment information.

Note_12_Income_Taxes

Note 12 - Income Taxes	9 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Tax Disclosure [Text Block]	'
	12	Income Taxes
	The Company uses an estimated annual effective tax rate, which is based on expected annual income, statutory tax rates and tax planning opportunities available in the various jurisdictions in which the Company operates, to determine its quarterly provision for income taxes.
	The Company had income tax expenses of $30,000 and income tax benefit of $383,000 from continuing operations for the three months ended September 30, 2014 and the corresponding period of 2013, respectively, and income tax expense of $90,000 and income tax benefit of $1,943,000 for the nine months ended September 30, 2014 and the corresponding period of 2013, respectively. The Company’s effective tax rates were approximately 1.3% and 40.3% for the three months ended September 30, 2014 and 2013, respectively, and (2.8%) and 37.6% for the nine months ended September 30, 2014 and 2013, respectively.  For the nine months ended September 30, 2014 and September 30, 2013, the Company treated the goodwill impairment loss of approximately $380,000 recorded for our SYA subsidiary (in the second quarter of 2014) and the goodwill impairment loss of approximately $1,149,000 recorded for our CHPRC reporting unit (recorded in the second quarter of 2013) as discrete items and therefore were not included in our estimated effective tax rates for the nine month ended September 30, 2014 and corresponding period of 2013 in accordance with ASC 740-270-30-8 (see Note 5 – “Other Intangible Assets and Goodwill” for further information regarding these goodwill impairments). The lower tax rate for the three and nine months ended September 30, 2014 as compared to the corresponding period of 2013 was primarily the result of the Company recording a full valuation allowance on its net deferred tax assets.

Note_13_Subsequent_Events

Note 13 - Subsequent Events	9 Months Ended
	Sep. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Events [Text Block]	'
	13	Subsequent Events
	Consulting Agreement
	On October 17, 2014, the Company’s Compensation and Stock Option Committee (“Compensation Committee”) and the Board of Directors (“Board”) approved a consulting agreement with John Climaco (a director of the Company), with Mr. Climaco abstaining. The Company and Mr. Climaco entered into the consulting agreement on October 17, 2014. Mr. Climaco is also is a member of the Strategic Advisory Committee of the Board. Pursuant to the consulting agreement, the services to be provided by the Consultant shall include, among other things, the following:
		●	Review the Company’s operations to restructure costs to render the Company more competitive;
		●	Evaluate all functions, including but not limited to sales, marketing, accounting, operations, and executive management as well as cost structures for each facility;
		●	Assist in the development of the Company’s strategy opportunity and other initiatives, including but not limited to the development of the Company’s medical isotope technology; and
		●	Other assignments as determined by the Board.
	The Consultant shall be paid $22,000 per month plus reasonable expenses. The agreement shall continue unless terminated by either party for any reason or no reason by providing thirty (30) days written notice to the other party. The Consultant shall remain on the Company’s Board of Director until the expiration of the term.

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
New Accounting Pronouncements, Policy [Policy Text Block]	'
	Recently Adopted Accounting Standards
	In April 2014, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2014-08, “Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity.” ASU 2014-08, among other things, raises the threshold for disposals to qualify as discontinued operations. Under ASU 2014-08, a discontinued operation is (1) a component of an entity or group of components that has been disposed of by sale, disposed of other than by sale or is classified as held for sale that represents a strategic shift that has or will have a major effect on an entity’s operations and financial results or (2) an acquired business or nonprofit activity that is classified as held for sale on the date of the acquisition. ASU 2014-08 also requires additional disclosures for discontinued operations and new disclosures for individually material disposal transactions that do not meet the definition of a discontinued operation. This ASU is effective for annual periods beginning on or after December 15, 2014 and interim periods within that year. Early adoption of ASU 2014-08 is permitted but only for disposals (or classifications as held for sale) that have not been reported in financial statements previously issued or available for issue. The Company elected to early adopt ASU 2014-08 during the second quarter of 2014. On April 3, 2014, the Company’s Board of Directors (“Board”) approved management to pursue the sale of our wholly owned subsidiary, SYA. On July 29, 2014, the Company completed the divestiture of SYA. As a result of the adoption of ASU 2014-08, the Company has presented the divestiture of SYA within our continuing operations. The sale of SYA does not represent a strategic shift that has or will have a major effect on the Company's operations and financial results as defined by ASU 2014-08. The Company has continued to present discontinued operations as previously presented in the Company's fiscal 2013 Annual Report on Form 10-K for the discontinued operations prior to the adoption of ASU 2014-08 (see “Note 4 - Divestitures and Discontinued Operations” for further detail of the divestiture of SYA).
	Recently Issued Accounting Standards
	In May 2014, the FASB issued ASU 2014-09, “Revenue from Contracts with Customers (Topic 606).” ASU 2014-09 provides a single, comprehensive revenue recognition model for all contracts with customers. The revenue guidance contains principles that an entity will apply to determine the measurement of revenue and timing of when it is recognized. The underlying principle is that an entity will recognize revenue to depict the transfer of goods or services to customers at an amount that the entity expects to be entitled to in exchange for those goods or services. The standard will be effective for the first interim period within annual reporting periods beginning after December 15, 2016 for public entities, with no early adoption permitted. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.
	In June 2014, the FASB issued ASU 2014-12, “Compensation Stock – Compensation (Topic 718).” ASU 2014-12 applies to all reporting entities that grant their employees share-based payments in which the terms of the award provide that a performance target that affects vesting could be achieved after the requisite service period. It requires that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition and follows existing accounting guidance for the treatment of performance conditions. The standard will be effective for annual periods and interim periods within those annual periods beginning after December 15, 2015, with early adoption permitted. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.
	In August 2014, the FASB issued ASU No. 2014-15, “Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern.” ASU 2014-15 requires management to assess an entity’s ability to continue as a going concern, and to provide related footnote disclosure in certain circumstances. The new standard will be effective for all entities in the first annual period ending after December 15, 2016. The Company is still evaluating the potential impact of adopting this guidance on our financial statements.

Note_4_Divestitures_and_Discon1

Note 4 - Divestitures and Discontinued Operations (Tables)	9 Months Ended
	Sep. 30, 2014
Discontinued Operations and Disposal Groups [Abstract]	'
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]	'
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
	(Amounts in Thousands)	2014			2013			2014			2013
	Net revenues	$	—		$	311		$	—		$	1,784
	Interest expense	$	(1	)	$	(7	)	$	(7	)	$	(20	)
	Operating loss from discontinued operations	$	(462	)	$	(369	)	$	(1,897	)	$	(342	)
	Income tax benefit	$	—		$	(129	)	$	—		$	(118	)
	(Loss) gain on insurance settlement of discontinued operations	$	(11	)	$	—		$	3,530		$	—
	(Loss) income from discontinued operations	$	(473	)	$	(240	)	$	1,633		$	(224	)

Note_5_Other_Intangible_Assets1

Note 5 - Other Intangible Assets and Goodwill (Tables)	9 Months Ended
	Sep. 30, 2014
Disclosure Text Block [Abstract]	'
Schedule of Finite-Lived Intangible Assets [Table Text Block]	'
				30-Sep-14								31-Dec-13
		Useful		Gross						Net		Gross					Net
		Lives		Carrying			Accumulated			Carrying		Carrying		Accumulated			Carrying
		(Years)		Amount			Amortization			Amount		Amount		Amortization			Amount
	Intangibles (amount in thousands)
	Patent	18-Aug		$	528		$	(158	)	$	370	$	514	$	(155	)	$	359
	Software	3			372			(305	)		67		379		(258	)		121
	Non-compete agreement	1.2			265			(265	)		—		265		(174	)		91
	Customer contracts	.5			790			(790	)		—		790		(790	)		—
	Customer relationships	12			3,370			(1,242	)		2,128		3,370		(961	)		2,409
	Total			$	5,325		$	(2,760	)	$	2,565	$	5,318	$	(2,338	)	$	2,980
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	'
						Amount
			Year			(In thousands)
			2014 (remaining)			$	117
			2015				459
			2016				419
			2017				385
			2018				355
						$	1,735

Note_6_Stock_Plans_and_Stock_B1

Note 6 - Stock Plans and Stock Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	'
		Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term			Aggregate Intrinsic Value
	Options outstanding Janury 1, 2014		362,800		$	9.53
	Granted		71,800			4.7
	Exercised		(1,257	)		2.79				$	2,319
	Forfeited		(187,000	)		10.04
	Options outstanding End of Period (1)		246,343			7.77		5.1		$	23,065
	Options Exercisable at September 30, 2014(1)		174,543		$	9.04		4.4		$	21,049
	Options Vested and expected to be vested at September 30, 2014		237,543		$	7.87		5		$	23,065
		Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term			Aggregate Intrinsic Value
	Options outstanding Janury 1, 2013		528,800		$	9.82
	Granted		18,000			2.79
	Exercised	─			─					$	─
	Forfeited		(156,000	)		8.28
	Options outstanding End of Period (2)		390,800			9.66		3.2		$	15,900
	Options Exercisable at September 30, 2013(2)		352,800		$	10.11		2.9		$	─
	Options Vested and expected to be vested at September 30, 2013		390,800		$	9.66		3.2		$	15,900
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	'
		Outside Director Stock Options Granted
		30-Sep-14			30-Sep-13
	Weighted-average fair value per share	$	2.73		$	1.96
	Risk -free interest rate (1)		2.63%			2.92%
	Expected volatility of stock (2)		59.59%			58.88%
	Dividend yield		None			None
	Expected option life (3) (years)		10			10
		Employee Stock Option Granted
		as of September 30, 2014
	Weighted-average fair value per share	$	2.88
	Risk -free interest rate (1)		1.91%
	Expected volatility of stock (2)		61.84%
	Dividend yield		None
	Expected option life (3) (years)		6
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	'
		Three Months Ended					Nine Months Ended
	Stock Options	September 30,					September 30,
		2014			2013		2014			2013
	Employee Stock Options	$	12,000		$	22,000	$	(27,000	)	$	58,000
	Director Stock Options		3,000			4,000		25,000			21,000
	Total	$	15,000		$	26,000	$	(2,000	)	$	79,000

Note_8_Income_Loss_Per_Share_T

Note 8 - Income (Loss) Per Share (Tables)	9 Months Ended
	Sep. 30, 2014
Earnings Per Share [Abstract]	'
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	'
		Three Months Ended						Nine Months Ended
		September 30,						September 30,
		(Unaudited)						(Unaudited)
	(Amounts in Thousands, Except for Per Share Amounts)	2014			2013			2014			2013
	Income (loss) per share from continuing operations attributable to Perma-Fix Environmental Services, Inc. common stockholders
	Income (loss) from continuing operations	$	2,344		$	(568	)	$	(3,720	)	$	(4,372	)
	Basic income (loss) per share	$	0.2		$	(.05	)	$	(.32	)	$	(.39	)
	Diluted income (loss) per share	$	0.2		$	(.05	)	$	(.32	)	$	(.39	)
	Loss per share from discontinued operations attributable to Perma-Fix Environmental Services, Inc. common stockholders
	Loss from discontinued operations	$	(462	)	$	(240	)	$	(1,897	)	$	(224	)
	Basic loss per share	$	(.04	)	$	(.02	)	$	(.17	)	$	(.02	)
	Diluted loss per share	$	(.04	)	$	(.02	)	$	(.17	)	$	(.02	)
	(Loss) income per share from insurance settlement of discontinued operations, net of taxes attributable to Perma-Fix Environmental Services, Inc. common stockholders
	(Loss) gain on insurance settlement of discontinued operations, net of taxes	$	(11	)	$	―		$	3,530		$	―
	Basic income per share	$	―		$	―		$	0.31		$	―
	Diluted income per share	$	―		$	―		$	0.31		$	―
	Weighted average common shares outstanding – basic		11,449			11,353			11,434			11,292
	Potential shares exercisable under stock option plans		8		―			―			―
	Potential shares upon exercise of Warrants		33		―			―			―
	Weighted average shares outstanding – diluted		11,490			11,353			11,434			11,292
	Potential shares excluded from above weighted average share calculations due to their anti-dilutive effect include:
	Upon exercise of stock options		207			391			207			373
	Upon exercise of Warrants	―			―			―			―

Note_9_Long_Term_Debt_Tables

Note 9 - Long Term Debt (Tables)	9 Months Ended
	Sep. 30, 2014
Disclosure Text Block [Abstract]	'
Schedule of Long-term Debt Instruments [Table Text Block]	'
	(Amounts in Thousands)	September 30,		December 31,
		2014		2013
	Revolving Credit facility dated October 31, 2011, borrowings based upon eligible accounts receivable, subject to monthly borrowing base calculation, variable interest paid monthly at our option of prime rate (3.25% at September 30, 2014) plus 2.0% or London Interbank Offer Rate ("LIBOR") plus 3.0%, balance due October 31, 2016. Effective interest rate for the first nine months of 2014 was 4.2%. (1)	$	—	$	—
	Term Loan dated October 31, 2011, payable in equal monthly installments of principal of $190, balance due in October 31, 2016, variable interest paid monthly at option of prime rate plus 2.5% or LIBOR plus 3.5%. Effective interest rate for the first nine months of 2014 was 3.8%. (1)		9,523		11,238
	Promissory Note dated February 12, 2013, payable in monthly installments of $10, which includes interest and principal, starting February 28, 2013, interest accrues at annual rate of 6.0%, balance due January 31, 2015. (2)		40		127
	Promissory Note dated August 2, 2013, payable in twelve monthly installments of interest only, starting September 1, 2013 and twenty-four monthly installments of $125 in principal plus accrued interest. Interest accrues at annual rate of 2.99%. (2) (3)		2,717		2,777
	Various capital lease and promissory note obligations, payable 2014 to 2016, interest at rates ranging from 5.2% to 6.0%.		64		141
			12,344		14,283
	Less current portion of long-term debt		3,765		2,876
	Less long-term debt related to assets held for sale		8		35
		$	8,571	$	11,372

Note_11_Operating_Segments_Tab

Note 11 - Operating Segments (Tables)	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Schedule of Segment Reporting Information, by Segment [Table Text Block]	'
	Segment Reporting for the Quarter Ended September 30, 2014
		Treatment			Services			Segments			Corporate (1)			PF Medical			Consolidated
								Total						S.A. (1)			Total
	Revenue from external customers	$	12,705		$	4,200		$	16,905		$	—			—		$	16,905
	Intercompany revenues		—			19			19			—			—			—
	Gross profit		4,943			638			5,581			—			—			5,581
	Interest income	—				—			—			7			—			7
	Interest expense		(10	)		—			(10	)		(128	)		—			(138	)
	Interest expense-financing fees		—			—			—			(52	)		—			(52	)
	Depreciation and amortization		748			213			961			12			—			973
	Segment profit (loss)		3,985			10			3,995			(1,422	)		(229	)		2,344
	Expenditures for segment assets		3			39			42			—			—			42
	Segment Reporting for the Quarter Ended September 30, 2013
		Treatment			Services			Segments			Corporate (1)			PF Medical			Consolidated
								Total						S.A. (1)			Total
	Revenue from external customers	$	8,929		$	10,143		$	19,072		$	—			—		$	19,072
	Intercompany revenues		82			11			93			—			—			—
	Gross profit		1,801			1,328			3,129			—			—			3,129
	Interest income		—			—			—			8			—			8
	Interest expense		(10	)		(1	)		(11	)		(241	)		—			(252	)
	Interest expense-financing fees		—			—			—			(40	)		—			(40	)
	Depreciation and amortization		999			248			1,247			20			—			1,267
	Segment profit (loss)		616			387			1,003			(1,571	)		—			(568	)
	Expenditures for segment assets		192			6			198			—			—			198
	Segment Reporting for the Nine Months Ended September 30, 2014
		Treatment			Services			Segments			Corporate (1)			PF Medical			Consolidated
								Total						S.A. (1)			Total
	Revenue from external customers	$	29,773		$	10,333		$	40,106		$	—			—		$	40,106
	Intercompany revenues		—			64			64			—			—			—
	Gross profit		6,379			853			7,232			—			—			7,232
	Interest income		—			—			—			20			—			20
	Interest expense		(35	)		(1	)		(36	)		(469	)		—			(505	)
	Interest expense-financing fees		—			2			2			(135	)		—			(133	)
	Depreciation and amortization		2,535			709			3,244			38			—			3,282
	Segment profit (loss)		2,977			(1,981	)		996			(4,302	)		(414	)		(3,720	)
	Expenditures for segment assets		334			41			375			—			—			375
	Segment Reporting for the Nine Months Ended September 30, 2013
		Treatment			Services			Segments			Corporate (1)			PF Medical			Consolidated
								Total						S.A. (1)			Total
	Revenue from external customers	$	26,379		$	35,306		$	61,685		$	—			—		$	61,685
	Intercompany revenues		1,149			66			1,215			—			—			—
	Gross profit		3,968			3,722			7,690			—			—			7,690
	Interest income		—			—			—			27			—			27
	Interest expense		(38	)		3			(35	)		(562	)		—			(597	)
	Interest expense-financing fees		—			—			—			(87	)		—			(87	)
	Depreciation and amortization		3,063			708			3,771			72			—			3,843
	Segment profit (loss)		524			(432	)		92			(4,528	)		—			(4,436	)
	Expenditures for segment assets		367			6			373			—			—			373

Note_1_Basis_of_Presentation_D

Note 1 - Basis of Presentation (Details) (USD $)	3 Months Ended			9 Months Ended
	Sep. 30, 2014	Jun. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Note 1 - Basis of Presentation (Details) [Line Items]	'	'	'	'	'	'
Retained Earnings (Accumulated Deficit)	($57,165,000)	'	'	($57,165,000)	'	($55,078,000)
Net Income (Loss) Attributable to Parent	1,871,000	'	-808,000	-2,087,000	-4,596,000	'
Disposal Group, Including Discontinued Operation, Other Income	-11,000	'	'	3,530,000	'	'
Working Capital Deficit	226,000	'	'	226,000	'	'
Revenue, Net	16,905,000	'	19,072,000	40,106,000	61,685,000	'
Backlog	10,681,000	'	'	10,681,000	'	'
Increase in Backlog	4,604,000	'	'	2,986,000	'	'
Gains (Losses) on Restructuring of Debt	'	37,000	65,000	'	'	'
Perma-Fix of South Georgia [Member]	'	'	'	'	'	'
Note 1 - Basis of Presentation (Details) [Line Items]	'	'	'	'	'	'
Disposal Group, Including Discontinued Operation, Other Income	'	'	'	$3,530,000	'	'

Note_3_Reduction_in_Authorized1

Note 3 - Reduction in Authorized Shares (Details)	Sep. 30, 2014	Sep. 19, 2014	Sep. 18, 2014	Dec. 31, 2013
Reduction Of Authorized Shares [Abstract]	'	'	'	'
Common Stock, Shares Authorized	30,000,000	30,000,000	75,000,000	75,000,000

Note_4_Divestitures_and_Discon2

Note 4 - Divestitures and Discontinued Operations (Details) (USD $)

0 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

9 Months Ended

12 Months Ended

0 Months Ended

3 Months Ended

0 Months Ended

3 Months Ended

6 Months Ended

9 Months Ended

12 Months Ended

Aug. 14, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Jul. 29, 2014

Sep. 30, 2014

Jul. 29, 2014

Jun. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Other Expense [Member]

Property and Equipment [Member]

Property and Equipment [Member]

For Expenses, Clean-up Costs and Business Interruption Recoveries[Member]

For Expenses, Clean-up Costs and Business Interruption Recoveries[Member]

Remaining [Member]

SYA [Member]

SYA [Member]

SYA [Member]

PFSG [Member]

PFSG [Member]

PFSG [Member]

PFSG [Member]

PFSG [Member]

SYA [Member]

PFSG [Member]

PFSG [Member]

PFSG [Member]

PFSG [Member]

PFSG [Member]

Note 4 - Divestitures and Discontinued Operations (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Divestiture of Businesses

'

'

'

'

'

'

'

'

'

'

'

$1,300,000

'

'

'

'

'

'

'

Disposal Group, Capital Stock Sold, Percentage

'

'

'

'

'

'

'

'

'

'

'

'

'

100.00%

'

'

'

'

'

Disposal Group, Working Capital Adjustment

'

'

'

'

'

'

'

'

'

'

'

60,000

-42,000

'

'

'

'

'

'

Escrow Deposit

'

'

'

'

'

'

'

'

'

'

'

'

'

50,000

'

'

'

'

'

Escrow Deposit, Term

'

'

'

'

'

'

'

'

'

'

'

'1 year

'

'

'

'

'

'

'

Disposal Group, Including Discontinued Operation, Other Expense

'

'

'

'

'

'

'

'

'

'

'

'

92,000

'

'

'

'

'

'

Gain (Loss) on Disposition of Business

'

'

'

-48,000

'

-48,000

'

'

'

'

'

'

-48,000

'

'

'

'

'

'

Discontinued Operation, Tax Effect of Other Income (Loss) from Disposition of Discontinued Operation

'

'

'

'

'

'

'

'

'

'

'

'

0

'

'

'

'

'

'

Disposal Group, Including Discontinued Operation, Revenue

'

'

311,000

'

1,784,000

'

'

'

'

'

'

'

2,564,736

'

'

'

'

'

'

Disposal Group, Including Discontinued Operation, Gross Profit (Loss)

'

'

'

'

'

'

'

'

'

'

'

'

-621,288

'

'

'

'

'

'

Number of Previously Shut Down Locations

'

2

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Maximum Deductible Amount in Insurance for General Liability

300,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Insurance Settlement, Investing Activities

'

'

'

'

'

'

5,727,000

1,750,000

2,735,000

1,914,000

'

'

'

'

3,850,000

3,850,000

'

8,462,000

3,664,000

Disposal Group, Including Discontinued Operation, Other Income

'

-11,000

'

3,530,000

'

'

'

'

'

'

'

'

'

'

'

-11,000

'

3,530,000

'

Gain (Loss) on Disposition of Property Plant Equipment

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

2,977,000

'

Insurance Recoveries

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

553,000

'

'

'

Tangible Asset Impairment Charges

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

38,000

685,000

723,000

'

Intangible Assets, Net (Excluding Goodwill)

'

'

'

'

'

'

'

'

'

'

$0

'

'

'

'

'

'

'

'

Note_4_Divestitures_and_Discon3

Note 4 - Divestitures and Discontinued Operations (Details) - Results of Discontinued Operations (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Results of Discontinued Operations [Abstract]	'	'	'	'
Net revenues	'	$311	'	$1,784
Interest expense	-1	-7	-7	-20
Operating loss from discontinued operations	-462	-369	-1,897	-342
Income tax benefit	'	-129	'	-118
(Loss) gain on insurance settlement of discontinued operations	-11	'	3,530	'
(Loss) income from discontinued operations	($473)	($240)	$1,633	($224)

Note_5_Other_Intangible_Assets2

Note 5 - Other Intangible Assets and Goodwill (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Note 5 - Other Intangible Assets and Goodwill (Details) [Line Items]	'	'	'	'
Number of Definite Lived Permit	'	'	1	'
Amortization of Intangible Assets	$149,000	$185,000	$501,000	$528,000
Goodwill, Impairment Loss	'	'	380,000	1,149,000
SYA [Member]	'	'	'	'
Note 5 - Other Intangible Assets and Goodwill (Details) [Line Items]	'	'	'	'
Goodwill, Impairment Loss	380,000	'	'	'
CH Plateau Remediation Company [Member]	'	'	'	'
Note 5 - Other Intangible Assets and Goodwill (Details) [Line Items]	'	'	'	'
Goodwill, Impairment Loss	'	$1,149,000	'	'

Note_5_Other_Intangible_Assets3

Note 5 - Other Intangible Assets and Goodwill (Details) - Other Intangible Assets (USD $)	9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	$5,325	$5,318
Accumulated Amortization	-2,760	-2,338
Net Carrying Amount	2,565	2,980
Patents [Member] | Minimum [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Useful Lives (Years)	'8 years	'
Patents [Member] | Maximum [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Useful Lives (Years)	'18 years	'
Patents [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Gross Carrying Amount	528	514
Accumulated Amortization	-158	-155
Net Carrying Amount	370	359
Computer Software, Intangible Asset [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Useful Lives (Years)	'3 years	'
Gross Carrying Amount	372	379
Accumulated Amortization	-305	-258
Net Carrying Amount	67	121
Noncompete Agreements [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Useful Lives (Years)	'1 year 73 days	'
Gross Carrying Amount	265	265
Accumulated Amortization	-265	-174
Net Carrying Amount	'	91
Customer Contracts [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Useful Lives (Years)	'5 years	'
Gross Carrying Amount	790	790
Accumulated Amortization	-790	-790
Customer Relationships [Member]	'	'
Finite-Lived Intangible Assets [Line Items]	'	'
Useful Lives (Years)	'12 years	'
Gross Carrying Amount	3,370	3,370
Accumulated Amortization	-1,242	-961
Net Carrying Amount	$2,128	$2,409

Note_5_Other_Intangible_Assets4

Note 5 - Other Intangible Assets and Goodwill (Details) - Summary of Expected Amortization Over the Next Five Years (USD $)	Sep. 30, 2014
In Thousands, unless otherwise specified
Summary of Expected Amortization Over the Next Five Years [Abstract]	'
	$117
	459
	419
	385
	355
	$1,735

Note_6_Stock_Plans_and_Stock_B2

Note 6 - Stock Plans and Stock Based Compensation (Details) (USD $)

9 Months Ended

9 Months Ended

0 Months Ended

0 Months Ended

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Dec. 31, 2012

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Sep. 18, 2014

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Jul. 10, 2014

Jul. 25, 2011

Jul. 10, 2014

Employee Stock Option [Member]

Employee Stock Option [Member]

Employee Stock Option [Member]

Director Stock Options [Member]

Director Stock Options [Member]

Non Qualified Stock Option Agreement [Member]

Minimum [Member]

Minimum [Member]

Maximum [Member]

Maximum [Member]

Chief Operating Officer [Member]

Chief Operating Officer [Member]

The 2010 Stock Option Plan [Member]

Contractual Term with One-fifth Yearly Vesting [Member]

Contractual Term with One-third Yearly Vesting [Member]

The 2004 And 2010 Stock Option Plans [Member]

The 2003 Outside Directors Stock Plan [Member]

The 2003 Outside Directors Stock Plan [Member]

The 2010 Stock Option Plan [Member]

The 2010 Stock Option Plan [Member]

Note 6 - Stock Plans and Stock Based Compensation (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Share Based Compensation Maximum Contractual Term

'

'

'

'

'10 years

'6 years

'

'

'10 years

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period

'

'

'

'

'5 years

'3 years

'

'

'6 months

'6 months

'

'

'

'

'

'3 years

'3 years

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)

71,800

18,000

'

'

'

'

'

'

'

16,800

'

'

'

'

45,000

60,000

55,000

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term

'5 years 36 days

[1]

'3 years 73 days

[2]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'6 years

Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price (in Dollars per share)

$4.70

$2.79

'

'

'

'

'

'

'

$3.70

'

'

'

'

'

$7.85

$5

Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period

'

'

'

'

'

'

'

'

'

'10 years

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number (in Shares)

246,343

[1]

390,800

[2]

362,800

528,800

'

'

76,000

170,343

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number (in Shares)

237,543

390,800

'

'

'

'

21,000

153,543

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number (in Shares)

174,543

[1]

352,800

[2]

'

'

'

'

21,000

153,543

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price (in Dollars per share)

$7.77

[1]

$9.66

[2]

$9.53

$9.82

'

'

$7.13

$9.30

'

'

$2.79

'

$14.75

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term

'4 years 146 days

[1]

'2 years 328 days

[2]

'

'

'

'

'109 days

'4 years 328 days

'

'

'

'

'

'

'

'

'

Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price (in Dollars per share)

$9.04

[1]

$10.11

[2]

'

'

'

'

'

'

'

'

'

$5.50

'

$14.75

'

'

'

Reduction in Stock Based Compensation Expense (in Dollars)

$54,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized (in Dollars)

181,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Remaining Fiscal Year (in Dollars)

36,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized In Year Two (in Dollars)

73,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized In Year Three (in Dollars)

53,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized In Year Four (in Dollars)

$19,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

[1]

Options with exercise prices ranging from $2.79 to $14.75

[2]

Options with exercise prices ranging from $5.50 to $14.75

Note_6_Stock_Plans_and_Stock_B3

Note 6 - Stock Plans and Stock Based Compensation (Details) - Company Stock Plan (USD $)	9 Months Ended
In Thousands, except Share data, unless otherwise specified	Sep. 30, 2014		Sep. 30, 2013
Company Stock Plan [Abstract]	'		'
Shares	362,800		528,800
Weighted Average Exercise Price	$9.53		$9.82
Shares	71,800		18,000
Weighted Average Exercise Price	$4.70		$2.79
Shares	-1,257		'
Weighted Average Exercise Price	$2.79		'
Aggregate Intrinsic Value	$2,319		'
Shares	-187,000		-156,000
Weighted Average Exercise Price	$10.04		$8.28
Shares	246,343	[1]	390,800	[2]
Weighted Average Exercise Price	$7.77	[1]	$9.66	[2]
Weighted Average Remaining Contractual Term	'5 years 36 days	[1]	'3 years 73 days	[2]
Aggregate Intrinsic Value	23,065	[1]	15,900	[2]
Shares	174,543	[1]	352,800	[2]
Weighted Average Exercise Price	$9.04	[1]	$10.11	[2]
Weighted Average Remaining Contractual Term	'4 years 146 days	[1]	'2 years 328 days	[2]
Aggregate Intrinsic Value	21,049	[1]	'	[2]
Shares	237,543		390,800
Weighted Average Exercise Price	$7.87		$9.66
Weighted Average Remaining Contractual Term	'5 years		'3 years 73 days
Aggregate Intrinsic Value	$23,065		$15,900
[1]	Options with exercise prices ranging from $2.79 to $14.75
[2]	Options with exercise prices ranging from $5.50 to $14.75

Note_6_Stock_Plans_and_Stock_B4

Note 6 - Stock Plans and Stock Based Compensation (Details) - Black-Scholes Valuation Model Assumptions (USD $)	9 Months Ended
	Sep. 30, 2014		Sep. 30, 2014		Sep. 30, 2013
			Director Stock Options [Member]		Employee Stock Option [Member]
Note 6 - Stock Plans and Stock Based Compensation (Details) - Black-Scholes Valuation Model Assumptions [Line Items]	'		'		'
Weighted-average fair value per share (in Dollars per share)	$2.88		$2.73		$1.96
Risk -free interest rate (1)	1.91%	[1]	2.63%	[1]	2.92%	[1]
Expected volatility of stock (2)	61.84%	[2]	59.59%	[2]	58.88%	[2]
Expected option life (3) (years)	'6 years	[3]	'10 years	[3]	'10 years	[3]
[1]	The risk-free interest rate is based on the U.S. Treasury yield in effect at the grant date over the expected term of the option.
[2]	The expected volatility is based on historical volatility from our traded Common Stock over the expected term of the option.
[3]	The expected option life is based on historical exercises and post-vesting data.

Note_6_Stock_Plans_and_Stock_B5

Note 6 - Stock Plans and Stock Based Compensation (Details) - Stock-Based Compensation Recognized (USD $)	3 Months Ended		9 Months Ended
In Thousands, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'
Stock Options	$15,000	$26,000	($2,000)	$79,000
Employee Stock Option [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'
Stock Options	12,000	22,000	-27,000	58,000
Director Stock Options [Member]	'	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]	'	'	'	'
Stock Options	$3,000	$4,000	$25,000	$21,000

Note_7_CEE_Opportunity_Partner1

Note 7 - CEE Opportunity Partners Poland S.A (n/k/a Perma-Fix Medical S.A.) (Details) (USD $)	1 Months Ended	0 Months Ended			4 Months Ended	11 Months Ended	4 Months Ended	6 Months Ended	3 Months Ended
	Sep. 30, 2014	Apr. 04, 2014	Apr. 04, 2014	Aug. 31, 2014	Jan. 31, 2015	Aug. 17, 2015	Jan. 31, 2015	Aug. 17, 2015	Sep. 30, 2014
		CEE Opportunity Partners Poland S.A. [Member]	CEE Opportunity Partners Poland S.A. [Member]	Series E Common Stock [Member]	Series E Common Stock [Member]	Series E Preferred Stock [Member]	Scenario, Forecast [Member]	Scenario, Forecast [Member]	PF Medical S.A., Formerly CEE Opportunity Partners Poland S.A. [Member]
				Private Placement [Member]	Scenario, Forecast [Member]	Scenario, Forecast [Member]	PF Medical S.A., Formerly CEE Opportunity Partners Poland S.A. [Member]	PF Medical S.A., Formerly CEE Opportunity Partners Poland S.A. [Member]
				PF Medical S.A., Formerly CEE Opportunity Partners Poland S.A. [Member]	PF Medical S.A., Formerly CEE Opportunity Partners Poland S.A. [Member]	PF Medical S.A., Formerly CEE Opportunity Partners Poland S.A. [Member]
Note 7 - CEE Opportunity Partners Poland S.A (n/k/a Perma-Fix Medical S.A.) (Details) [Line Items]	'	'	'	'	'	'	'	'	'
Capital Investment in Publicly Traded Shell Company, Percentage Acquired	'	80.00%	'	'	'	'	'	'	'
Capital Transaction, Purchase Price	'	'	$1	'	'	'	'	'	'
Common Stock, Value, Subscriptions	'	'	'	2,550,000	'	'	'	'	'
Cash Received From Capital Transaction, Held in Escrow Accounts	'	'	'	'	'	'	'	'	1,247,000
Series E Common Stock SharesTo Be Issued (in Shares)	'	'	'	'	'	'	56,680	68,161	125,159
Cash From Capital Transaction, to Be Received	'	'	'	'	$553,000	$750,000	'	'	'
Capital Investment in Publicly Traded Shell Company, Percentage Of Outstanding Shares	64.00%	'	'	'	'	'	'	'	'
Capital Investment in Publicly Traded Shell Company, Percentage Of Outstanding Shares If Not Paid	68.00%	'	'	'	'	'	'	'	'

Note_8_Income_Loss_Per_Share_D

Note 8 - Income (Loss) Per Share (Details) - Earnings Per Share (USD $)	3 Months Ended		9 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income (loss) per share from continuing operations attributable to Perma-Fix Environmental Services, Inc. common stockholders	'	'	'	'
Income (loss) from continuing operations (in Dollars)	$2,344	($568)	($3,720)	($4,372)
Basic income (loss) per share	$0.20	($0.05)	($0.32)	($0.39)
Diluted income (loss) per share	$0.20	($0.05)	($0.32)	($0.39)
Loss per share from discontinued operations attributable to Perma-Fix Environmental Services, Inc. common stockholders	'	'	'	'
Loss from discontinued operations (in Dollars)	-462	-240	-1,897	-224
Basic loss per share	($0.04)	($0.02)	($0.17)	($0.02)
Diluted loss per share	($0.04)	($0.02)	($0.17)	($0.02)
(Loss) income per share from insurance settlement of discontinued operations, net of taxes attributable to Perma-Fix Environmental Services, Inc. common stockholders	'	'	'	'
(Loss) gain on insurance settlement of discontinued operations, net of taxes (in Dollars)	($11)	'	$3,530	'
Basic income per share	'	'	$0.31	'
Diluted income per share	'	'	$0.31	'
Weighted average common shares outstanding b basic (in Shares)	11,449	11,353	11,434	11,292
Potential shares exercisable under stock option plans (in Shares)	8	'	'	'
Potential shares upon exercise of Warrants (in Shares)	33	'	'	'
Weighted average shares outstanding b diluted (in Shares)	11,490	11,353	11,434	11,292
Upon exercise of stock options (in Shares)	207	391	207	373

Note_9_Long_Term_Debt_Details

Note 9 - Long Term Debt (Details) (USD $)

3 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

0 Months Ended

9 Months Ended

0 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

3 Months Ended

Jun. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Apr. 14, 2014

Oct. 31, 2011

Oct. 31, 2011

Oct. 31, 2011

Sep. 30, 2014

Feb. 12, 2013

Feb. 12, 2013

Aug. 02, 2013

Sep. 30, 2014

Aug. 02, 2013

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Jun. 30, 2014

Sep. 30, 2014

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Amended Loan Agreement [Member]

Amended Loan Agreement [Member]

Agreement [Member]

Agreement [Member]

Agreement [Member]

Promissory Notes and Installment Agreements [Member]

Promissory Notes and Installment Agreements [Member]

Promissory Notes and Installment Agreements [Member]

Promissory Note dated August 2, 2013 [Member]

Promissory Note dated August 2, 2013 [Member]

Promissory Note dated August 2, 2013 [Member]

Promissory Note dated August 2, 2013 [Member]

Promissory Note dated August 2, 2013 [Member]

Revolving Credit Facility [Member]

PFSG [Member]

PFSG [Member]

PFSG [Member]

PFSG [Member]

PNC Bank [Member]

Revolving Credit Facility [Member]

Revolving Credit Facility [Member]

Term Loan [Member]

Term Loan [Member]

Revolving Credit Facility [Member]

Promissory Note dated February 12, 2013 ("New Note") [Member]

Promissory Note dated February 12, 2013 ("New Note") [Member]

Promissory Note Prior to February 12, 2013 [Member]

Lenders [Member]

Lenders [Member]

Lenders [Member]

PNC Bank [Member]

PNC Bank [Member]

PNC Bank [Member]

PNC Bank [Member]

PNC Bank [Member]

TNC [Member]

TNC [Member]

TNC [Member]

Note 9 - Long Term Debt (Details) [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Unamortized Discount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

($158,000)

($223,000)

'

'

'

'

'

'

Line of Credit Facility, Maximum Borrowing Capacity

'

'

'

'

'

12,000,000

'

16,000,000

18,000,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Debt Instrument, Periodic Payment, Principal

'

'

'

'

'

'

190,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Gains (Losses) on Restructuring of Debt

37,000

65,000

'

'

-37,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Insurance Settlement, Investing Activities

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

3,850,000

3,850,000

8,462,000

3,664,000

'

Line of Credit Facility Reduction

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,500,000

Debt Instrument, Fee Amount

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

15,000

Line of Credit Facility, Remaining Borrowing Capacity

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

8,558,000

'

'

'

'

'

Debt Instrument, Face Amount

'

'

'

'

'

'

'

'

'

'

230,000

1,460,000

'

'

'

'

'

'

'

'

'

'

'

Notes Payable

'

'

'

'

'

'

'

'

'

40,000

'

'

'

'

'

'

'

'

'

'

'

'

'

Number of Days for Trading of Common Stock to Determine Average Closing Price

'

'

'

'

'

'

'

'

'

'30 days

'

'

'

'

'

'

'

'

'

'

'

'

'

Proceeds from Issuance of Long-term Debt

'

'

'

'

'

'

'

'

'

'

'

'

3,000,000

'

'

'

'

'

'

'

'

'

'

Number of Shares Issued to Each Lender on Warrant (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

35,000

'

'

'

'

'

'

'

'

'

'

Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)

'

'

'

'

'

'

'

'

'

'

'

'

'

'

$2.23

'

'

'

'

'

'

'

'

Warrants Exercisable Term

'

'

'

'

'

'

'

'

'

'

'

'

'6 months

'

'

'

'

'

'

'

'

'

'

Warrants Not Settleable in Cash, Fair Value Disclosure

'

'

'

'

'

'

'

'

'

'

'

'

'

'

59,000

'

'

'

'

'

'

'

'

Common Stock, Shares, Issued (in Shares)

'

'

11,456,536

11,406,573

'

'

'

'

'

'

'

'

'

'

90,000

'

'

'

'

'

'

'

'

Number of Shares Received by each Lender (in Shares)

'

'

'

'

'

'

'

'

'

'

'

'

45,000

'

'

'

'

'

'

'

'

'

'

Stock Issued During Period, Value, Other

'

'

'

'

'

'

'

'

'

'

'

'

$200,000

'

'

'

'

'

'

'

'

'

'

Maximum Number of Payoffs of Shares in Terms of Outstanding Equity

'

'

'

'

'

'

'

'

'

'

'

'

'

20.00%

'

'

'

'

'

'

'

'

'

Note_9_Long_Term_Debt_Details_

Note 9 - Long Term Debt (Details) - Long-term Debt Instruments (USD $)	Sep. 30, 2014		Dec. 31, 2013
In Thousands, unless otherwise specified
Debt Instrument [Line Items]	'		'
Long-term debt	$12,344		$14,283
Less current portion of long-term debt	3,765		2,876
Less long-term debt related to assets held for sale	8		35
	8,571		11,372
Revolving Credit [Member]	'		'
Debt Instrument [Line Items]	'		'
Long-term debt	'	[1]	'	[1]
Term Loan [Member]	'		'
Debt Instrument [Line Items]	'		'
Long-term debt	9,523	[1]	11,238	[1]
Promissory Note dated February 12, 2013 ("New Note") [Member]	'		'
Debt Instrument [Line Items]	'		'
Long-term debt	40	[2]	127	[2]
Promissory Note dated August 2, 2013 [Member]	'		'
Debt Instrument [Line Items]	'		'
Long-term debt	2,717	[2],[3]	2,777	[2],[3]
Various Capital Lease and Promissory Note Obligations [Member]	'		'
Debt Instrument [Line Items]	'		'
Long-term debt	$64		$141
[1]	Our Revolving Credit facility is collateralized by our accounts receivable and our Term Loan is collateralized by our property, plant, andequipment.
[2]	Uncollateralized note.
[3]	Net of debt discount of ($158,000) and ($223,000) for September 30, 2014 and December 31, 2013, respectively. See "Promissory Notes" below for additional information.

Note_9_Long_Term_Debt_Details_1

Note 9 - Long Term Debt (Details) - Long-term Debt Instruments (Parentheticals) (USD $)	9 Months Ended
	Sep. 30, 2014
Revolving Credit [Member] | Prime Rate [Member]	'
Debt Instrument [Line Items]	'
Basis spread on variable rate	2.00%
Revolving Credit [Member] | London Interbank Offered Rate (LIBOR) [Member]	'
Debt Instrument [Line Items]	'
Basis spread on variable rate	3.00%
Revolving Credit [Member]	'
Debt Instrument [Line Items]	'
Effective interest rate	4.20%
Reference rate	3.25%
Term Loan [Member] | Prime Rate [Member]	'
Debt Instrument [Line Items]	'
Basis spread on variable rate	2.50%
Term Loan [Member] | London Interbank Offered Rate (LIBOR) [Member]	'
Debt Instrument [Line Items]	'
Basis spread on variable rate	3.50%
Term Loan [Member]	'
Debt Instrument [Line Items]	'
Effective interest rate	3.80%
Periodic payment, principal (in Dollars)	190,000
Promissory Note dated February 12, 2013 ("New Note") [Member]	'
Debt Instrument [Line Items]	'
Effective interest rate	6.00%
Periodic payment, principal (in Dollars)	10,000
Promissory Note dated August 2, 2013 [Member]	'
Debt Instrument [Line Items]	'
Effective interest rate	2.99%
Periodic payment, principal (in Dollars)	125,000
Various Capital Lease and Promissory Note Obligations [Member] | Minimum [Member]	'
Debt Instrument [Line Items]	'
Effective interest rate	5.20%
Various Capital Lease and Promissory Note Obligations [Member] | Maximum [Member]	'
Debt Instrument [Line Items]	'
Effective interest rate	6.00%

Note_10_Commitments_and_Contin1

Note 10 - Commitments and Contingencies (Details) (USD $)	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2014
Note 10 - Commitments and Contingencies (Details) [Line Items]	'	'
Maximum AllowableCoverageOfInsurancePolicy	$39,000,000	$39,000,000
Financial Assurance Coverage Amount Under Insurance Policy	38,679,000	38,679,000
Sinking Fund Related to Insurance Policy	15,424,000	15,424,000
Interest Earned on Sinking Fund	953,000	953,000
Interest Income on Sinking Fund During Period	5,000	15,000
Insurers Obligation to Entity on Termination of Contract	100.00%	100.00%
Financial Assurance Coverage Amount Under Second Insurance Policy	7,800,000	7,800,000
Annual Growth Rate of Financial Assurance Coverage Amount Under Second Insurance Policy	'	1.50%
Maximum Financial Assurance Coverage Amount Under Second Insurance Policy	8,200,000	8,200,000
Sinking Fund Related to Second Insurance Policy	5,902,000	5,902,000
Interest Earned on Sinking Fund Under Second Insurance Policy	202,000	202,000
Interest Income on Sinking Fund During Period Under Second Insurance Policy	1,000	4,000
Period of Finite Second Insurance Policy	'	'4 years
Minimum [Member]	'	'
Note 10 - Commitments and Contingencies (Details) [Line Items]	'	'
Renewal Fee for Additional Year Under Second Insurance Policy	'	41,000
Maximum [Member]	'	'
Note 10 - Commitments and Contingencies (Details) [Line Items]	'	'
Renewal Fee for Additional Year Under Second Insurance Policy	'	$46,000

Note_11_Operating_Segments_Det

Note 11 - Operating Segments (Details)	9 Months Ended
	Sep. 30, 2014
Segment Reporting [Abstract]	'
Number of Reportable Segments	2

Note_11_Operating_Segments_Det1

Note 11 - Operating Segments (Details) - Segment Financial Information (USD $)	3 Months Ended				9 Months Ended
	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
Segment Reporting Information [Line Items]	'		'		'		'
Revenue from external customers	$16,905,000		$19,072,000		$40,106,000		$61,685,000
Gross profit (loss)	5,581,000		3,129,000		7,232,000		7,690,000
Interest income	7,000		8,000		20,000		27,000
Interest expense	-138,000		-252,000		-505,000		-597,000
Interest expense-financing fees	-52,000		-40,000		-133,000		-87,000
Depreciation and amortization	973,000		1,267,000		3,282,000		3,843,000
Segment loss, net of taxes	2,344,000		-568,000		-3,720,000		-4,436,000
Expenditures for segment assets	42,000		198,000		375,000		373,000
Treatment [Member]	'		'		'		'
Segment Reporting Information [Line Items]	'		'		'		'
Revenue from external customers	12,705,000		8,929,000		29,773,000		26,379,000
Intercompany revenues	'		82,000		'		1,149,000
Gross profit (loss)	4,943,000		1,801,000		6,379,000		3,968,000
Interest expense	-10,000		-10,000		-35,000		-38,000
Depreciation and amortization	748,000		999,000		2,535,000		3,063,000
Segment loss, net of taxes	3,985,000		616,000		2,977,000		524,000
Expenditures for segment assets	3,000		192,000		334,000		367,000
Services [Member]	'		'		'		'
Segment Reporting Information [Line Items]	'		'		'		'
Revenue from external customers	4,200,000		10,143,000		10,333,000		35,306,000
Intercompany revenues	19,000		11,000		64,000		66,000
Gross profit (loss)	638,000		1,328,000		853,000		3,722,000
Interest expense	'		-1,000		-1,000		3,000
Interest expense-financing fees	'		'		2,000		'
Depreciation and amortization	213,000		248,000		709,000		708,000
Segment loss, net of taxes	10,000		387,000		-1,981,000		-432,000
Expenditures for segment assets	39,000		6,000		41,000		6,000
Segments Total [Member]	'		'		'		'
Segment Reporting Information [Line Items]	'		'		'		'
Revenue from external customers	16,905,000		19,072,000		40,106,000		61,685,000
Intercompany revenues	19,000		93,000		64,000		1,215,000
Gross profit (loss)	5,581,000		3,129,000		7,232,000		7,690,000
Interest expense	-10,000		-11,000		-36,000		-35,000
Interest expense-financing fees	'		'		2,000		'
Depreciation and amortization	961,000		1,247,000		3,244,000		3,771,000
Segment loss, net of taxes	3,995,000		1,003,000		996,000		92,000
Expenditures for segment assets	42,000		198,000		375,000		373,000
Corporate and Other [Member]	'		'		'		'
Segment Reporting Information [Line Items]	'		'		'		'
Revenue from external customers	'	[1]	'	[1]	'	[1]	'	[1]
Intercompany revenues	'	[1]	'	[1]	'	[1]	'	[1]
Gross profit (loss)	'	[1]	'	[1]	'	[1]	'	[1]
Interest income	7,000	[1]	8,000	[1]	20,000	[1]	27,000	[1]
Interest expense	-128,000	[1]	-241,000	[1]	-469,000	[1]	-562,000	[1]
Interest expense-financing fees	-52,000	[1]	-40,000	[1]	-135,000	[1]	-87,000	[1]
Depreciation and amortization	12,000	[1]	20,000	[1]	38,000	[1]	72,000	[1]
Segment loss, net of taxes	-1,422,000	[1]	-1,571,000	[1]	-4,302,000	[1]	-4,528,000	[1]
Expenditures for segment assets	'	[1]	'	[1]	'	[1]	'
PF Medical S.A. [Member]	'		'		'		'
Segment Reporting Information [Line Items]	'		'		'		'
Revenue from external customers	'	[1]	'	[1]	'	[1]	'	[1]
Intercompany revenues	'	[1]	'	[1]	'	[1]	'	[1]
Gross profit (loss)	'	[1]	'	[1]	'	[1]	'	[1]
Interest income	'	[1]	'	[1]	'	[1]	'	[1]
Interest expense	'	[1]	'	[1]	'	[1]	'	[1]
Interest expense-financing fees	'	[1]	'	[1]	'	[1]	'	[1]
Depreciation and amortization	'	[1]	'	[1]	'	[1]	'	[1]
Segment loss, net of taxes	-229,000	[1]	'	[1]	-414,000	[1]	'	[1]
Expenditures for segment assets	'	[1]	'	[1]	'	[1]	'	[1]
[1]	Amounts reflect the activity for corporate headquarters and PF Medical S.A. not included in the segment information.

Note_12_Income_Taxes_Details

Note 12 - Income Taxes (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Note 12 - Income Taxes (Details) [Line Items]	'	'	'	'
Income Tax Expense (Benefit)	$30,000	($383,000)	$90,000	($1,943,000)
Effective Income Tax Rate Reconciliation, Percent	1.30%	40.30%	-2.80%	37.60%
Goodwill, Impairment Loss	'	'	380,000	1,149,000
SYA [Member]	'	'	'	'
Note 12 - Income Taxes (Details) [Line Items]	'	'	'	'
Goodwill, Impairment Loss	'	'	380,000	380,000
CH Plateau Remediation Company [Member]	'	'	'	'
Note 12 - Income Taxes (Details) [Line Items]	'	'	'	'
Goodwill, Impairment Loss	'	'	$1,149,000	$1,149,000

Note_13_Subsequent_Events_Deta

Note 13 - Subsequent Events (Details) (Subsequent Event [Member], USD $)	0 Months Ended
	Oct. 17, 2014
Subsequent Event [Member]	'
Note 13 - Subsequent Events (Details) [Line Items]	'
Professional Fees	$22,000